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ABSTRACT 
Sepsis is one of the oldest and most elusive syndromes in medicine. It is 
characterized by a systemic inflammatory response leading to acute organ 
dysfunction. In the United States alone there are over 750,000 cases of sepsis each 
year, with a mortality rate between 20-50%. Sepsis is the second leading cause of 
death in the ICU and the tenth leading cause of death overall in the United States. 
Over half of all ICU resources are consumed in the treatment of sepsis. There are 
currently no effective therapies available against sepsis, all attempts to develop an 
effective therapy have failed. Respiratory infections are the leading cause of sepsis, 
leading to what is called pneumonic sepsis. The Gram-negative bacteria Klebsiella 
pneumoniae (KPn) is associated with upwards of 20% of all pneumonic sepsis 
cases. Utilizing a mouse model of pneumonic sepsis induced by intranasal infection 
of KPn, I studied the role that mammalian C-type lectin receptors (CLRs) play in 
the development and clearance of pneumonic sepsis. CLRs are primarily expressed 
on phagocytic immune cells of myeloid origin and are considered pattern 
recognition receptors that have the ability to shape the immune response by 
recognizing both pathogen associated molecular patterns and host damage 
associated molecular patterns in many different pathological conditions. From the 
pathogen perspective, I studied the effect KPn has on the immune cells and how 
that may impact the ability of KPn establish the infection.
ix 
 
In my first project, I examined the role of two CLRs, Macrophage Galactose Type 
Lectin 1 (MGL1) and Clec4e otherwise known as Mincle, in the development and 
clearance of pneumonic sepsis caused by KPn. This project was built on previous 
observations made by my advisor Dr. Jyotika Sharma which showed these two 
CLRs upregulated in the lung during KPn induced pneumonic sepsis. In regards to 
MGL1, I am the first author on the paper that we recently published in the Journal 
of Immunology “Macrophage Galactose-Type Lectin-1 Deficiency Is Associated with 
Increased Neutrophilia and Hyperinflammation in Gram-Negative Pneumonia” (J 
Immunol. 2016 Apr 1;196(7):3088-96. doi: 10.4049/jimmunol.1501790.). In this 
paper we showed that MGL1-/- mice were more susceptible to KPn infection, a 
phenotype that did not correlate with the systemic and local bacterial burden; the 
ability of macrophages and neutrophils to phagocytose and kill bacteria or 
neutrophil NETs. We demonstrated that the mechanism underlying the increased 
mortality of MGL1-/- mice was increased ability of neutrophils to infiltrate the lungs 
causing their overwhelming accumulation and severe neutrophil-mediated 
pathology in the lungs in the absence of MGL1. Mechanistic insights into the 
potential negative regulatory function of MGL1 in neutrophil infiltration, their 
clearance by efferocytosis as well as the process of granulopoiesis are some of the 
future directions of this work that are being perused in the laboratory. In the paper 
I co-authored on Mincle, “Protective Role of Mincle in Bacterial Pneumonia by 
Regulation of Neutrophil Mediated Phagocytosis and Extracellular Trap 
Formation” (Infect Dis. (2014) 209 (11): 1837-1846.doi: 10.1093/infdis/jit820), 
we showed that Mincle mediates two important bacterial clearance mechanisms i.e.  
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bacterial phagocytosis and extracellular trap (NET) formation by neutrophils. As a 
result, Mincle-/- mice are more susceptible to KPn infection as compared to the 
Mincle sufficient wild-type mice. This project is being led by Dr. Atul Sharma, a 
postdoctoral fellow in the lab. 
My second project examined the effect of KPn infection on the clearance of 
neutrophils by a process called efferocytosis. While performing experiments for the 
role of MGL1 in efferocytosis, I found that in comparison with the uninfected 
neutrophils, KPn infected cells were engulfed less efficiently by macrophages. As 
efferocytosis is a receptor mediated process, I discovered that while KPn infection 
increases the expression of repressive molecules called “Don’t Eat Me” signals on 
neutrophils, it is the modulation of distribution of a key “Eat Me” signal, 
phosphatidylserine (PtdSer) and the subsequent delay of apoptosis in neutrophils 
that is partially involved in KPn mediated inhibition of efferocytosis. Accordingly, 
KPn infected neutrophils also induce an alternative rout of programmed cell death 
called necroptosis. It is the combination of the “eat me” signal downregulation and 
the induction of necroptosis in KPn infected neutrophils that inhibit their efferocytic 
uptake by macrophages. A part of this data has been communicated for publication. 
Current work that I have led in the lab on this project involves determining what 
signaling mechanisms KPn is activating to decrease PtdSer as well as activation of 
necroptosis to inhibit the efferocytosis of infected PMNs.  
The overarching goal of this work was to increase the overall knowledge on the 
role CLRs play in pneumonic sepsis in terms of neutrophil turnover and how KPn 
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subverts these processes to its own advantage. I believe that this knowledge can be 
used to identify novel targets for effective therapy of sepsis as well as other 
inflammatory conditions. 
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CHAPTER 1 
INTRODUCTION 
Sepsis and Pneumonia: Healthcare burden and treatment 
Sepsis has been described for thousands of years and despite massive amounts of effort to 
better understand and treat sepsis, it is still a major challenge in medicine (1, 2). A recent 
study determined that there were over 31.5 million cases of sepsis worldwide, of which 
19.4 were severe sepsis, resulting in 5.3 million deaths annually (3). In the United States 
sepsis is the 11th leading cause of death and is considered a major healthcare burden by the 
Centers for Disease Control and Prevention, causing over an estimated 750,00 cases 
annually with a mortality rate of 20-50% depending on certain risk factors. Sepsis is the 
leading cause of death in non-coronary ICU patients in the US and effects 1 out of 3 ICU 
patients. An estimated $24.3 billion dollars is spent each year treating sepsis (2, 4-10). 
Patients who are immune-compromised, have chronic diseases such as cancer, diabetes, 
liver disease, or chronic obstructive pulmonary disease, as well as elderly individuals have 
the highest risk of developing sepsis or severe sepsis (11).  
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Respiratory infections and pneumonia in the lungs are the most common site of infection 
for sepsis, accounting for 40%-50% of all sepsis cases (2, 12, 13). Both Gram-positive and 
Gram-negative bacteria can cause sepsis, but in the lung Gram negative bacteria are the 
primary cause of infection. Gram negative infections also have the highest rate of mortality 
(14-16). Gram negative bacteria that belong to the Enterobacteriaceae family, such as E. 
coli and Klebsiella species are the leading cause of sepsis (12, 17, 18). 
The incidence of sepsis is on the rise with a 13% increase annually in the number of sepsis 
cases seen (11, 19, 20). While there has been an increase in the occurrence of sepsis over 
the past two decades, there has also been a decrease in the mortality rate of sepsis going 
down from 46.9% from 1991-1995 to 29% from 2006-2009 (10). The decrease in mortality 
rates has partially been due to advances in supportive care as well as better recognition of 
early sepsis due the improved definition of sepsis by the American College of Chest 
Physicians and Society for Critical Care Medicine Consensus Conference in 1991 and 
2001. The 1991 conference defined systemic inflammatory response syndrome (SIRS), 
sepsis, severe sepsis, and septic shock as a disease complex with varying degrees of 
severity based on a number of different criteria such as inflammation and organ failure. 
The 2001 conference revised the criteria for sepsis making it more specific by using clinical 
and laboratory criteria to identify sepsis (11, 21, 22). Despite this decrease in mortality 
rate, the morbidity associated with sepsis and the development of antibiotic resistance by 
bacterial pathogens continues to pose a healthcare threat and highlight the importance of 
understanding immune responses in order to identify new avenues for treatment strategies. 
The clinical signs of sepsis today include but are not limited to, increase or decrease in 
body temperature, heart rate, or white blood cell count, and elevated levels of plasma C-
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reactive protein due to an infection and systemic inflammation. Sepsis progresses to severe 
sepsis when organ dysfunction is seen. Septic shock occurs when there is a dangerous drop 
in blood pressure, due to complications of severe sepsis (11, 21, 22). Hallmarks used in the 
lab to identify sepsis include hypercytokinemia, with an initial increase in pro-
inflammatory cytokines and later increase in anti-inflammatory cytokines in conjunction 
with high pro-inflammatory cytokine levels, indicating a dysregulation of the immune 
response. The cytokine storm is followed closely by a dysregulation of the complement 
and coagulation systems, the dysregulation of the coagulation system can lead to vascular 
injury caused by disseminated intravascular coagulation (DIC). Vascular injury along with 
other organ dysfunctions leads to bacteremia or the presence of bacteria in the blood, as 
well as cell death. Bacteremia can spread the infection to other organs further driving the 
development of sepsis. Cell death causes the release of damage associated molecular 
patterns (DAMPs) and alarmins, endogenous molecules that are released upon tissue 
damage, which further drives inflammation and recruits cells neutrophils and other innate 
immune cells causing further sepsis development (Figure 1). All of these outcomes if not 
identified and treated quickly, ultimately leads to organ failure culminating in death. The 
development of sepsis occurs in a feed forward loop. As the disease progresses, the result 
of the initial inflammation recruits more innate immune cells, which lead to exaggeration 
of inflammation, cell death, and tissue injury. That in turn drives further inflammation and 
dysregulation of the immune system. This cycle will continue to feed on itself, until death 
or the cycle is broken in some way via treatment (1, 23). 
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Figure 1. The inflammatory network in sepsis 
During sepsis, homeostasis between the various biological systems of the inflammatory 
network is highly imbalanced. In the initiation of sepsis, the release of a large amount of 
damage-associated molecular patterns (DAMPs) from invading microorganisms and/or 
damaged host tissue results in the overstimulation of pattern-recognition receptors (PRRs) 
on immune cells. Activated immune cells release excessive amounts of pro-inflammatory 
mediators (resulting in a ‘cytokine storm’), free radicals and enzymes, which converts the 
normally beneficial effects of inflammation into an excessive response that damages the 
host. Activation of the adrenergic branch of the autonomic nervous system (ANS) and/or 
decreased activity of the cholinergic anti-inflammatory pathway (of the parasympathetic 
branch of the ANS) further amplifies the pro-inflammatory responses of neutrophils, 
macrophages and dendritic cells in sepsis. The presence of invading microorganisms or 
their products in the blood can cause systemic activation of the complement system, which 
results in the excessive generation of complement anaphylatoxins, which, at high 
concentrations, induce numerous harmful effects. Simultaneous activation of the 
coagulation system and the inhibition of fibrinolysis as a result of the pro-inflammatory 
environment and/or damaged endothelium can result in disseminated intravascular 
coagulation (DIC), which is a major complication of sepsis, and in the amplification of the 
inflammatory response. The complement, coagulation and fibrinolysis systems are tightly 
connected through direct interactions of serine proteases, and imbalances in each cascade 
are intensified in a positive-feedback loop.  
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Figure 1 cont. The inflammatory network in sepsis 
Finally, the sustained pro-inflammatory environment affects the functional state of immune 
effector cells, eventually causing the dysfunction of neutrophils and immunoparalysis. 
Alterations in leukocyte apoptosis in the later stages of sepsis further account for 
immunosuppression, which increases the susceptibility to secondary infections. 
Reproduced with permission from Nature Reviews Immunology. Permission # 
4126831477050 (23).  
 
Current treatment guidelines for sepsis dictate that antibiotic therapy be started within one 
hour of diagnosis and mortality increases by 6% every hour after that. Beyond, early 
recognition, broad-spectrum antibiotic therapy, and treatment of any symptoms, there are 
no other treatment options. There have been over 100 Phase II and Phase III clinical trials 
in the past 40 years and yet no FDA-approved drug for the use in treatment of sepsis has 
passed clinical trials (24-27). Despite significant efforts, the field is still a long way off 
from finding a treatment for this complex and deadly disorder. Sepsis, a complex immune 
disorder, is associated with dysregulation of many immune regulatory processes, which are 
not completely understood (23, 26-29). The majority of clinical trials have focused on one 
aspect of what causes sepsis, either the hyperimmune response, dysregulation of the 
coagulation system, or attempting to stimulate a specific immune function, all have failed. 
There have been 15 clinical trials utilizing anti-tumor necrosis-α (TNF-α) antibodies, due 
to the central role played by TNF- α in mediating inflammation. These studies were 
designed to target and prevent the “cytokine storm or hypercytokinemia” observed in sepsis 
patients, which is characterized by dysregulation and massive upregulation of both pro- 
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and anti-inflammatory cytokines (23, 27, 30). All these studies failed because they did not 
recognize the complexity of the disease, especially given the heterogenous patient 
population(28, 29). Xigris, an FDA approved drug to treat sepsis, was a recombinant 
activated protein C (APC) that targeted the disseminated intravascular coagulation (DIC), 
that caused vascular injury, a contributing factor to sepsis development. Unfortunately, in 
October 2011, the results of the PROWESS-SHOCK clinical trial were revealed, which 
failed to show overall efficacy of this drug for APC, and Xigris was pulled from the market 
(18, 27, 31). All this goes to show that sepsis as an immune disorder is too complex to be 
treated by targeting only one aspect of the dysfunction. There, there is a critical need to 
identify additional targets for drug development, which can be used as combination 
therapies to treat this complex immune disorder, as single molecule therapies have failed. 
Inflammatory Mechanisms in Sepsis 
Sepsis is characterized as an initial hyperimmune response; therefore, it is essential to 
understand the innate immune components that play a role in inflammation. The 
inflammatory response against an invading pathogen is initiated when pathogen associated 
molecular patterns (PAMPs) on the bacteria are recognized by pattern recognition receptors 
(PRRs) on tissue resident cells. The recognition of PAMPs by PRRs causes PRR-induced 
signal transduction pathways to be activated with the end result being the release of 
chemokines and cytokines, which recruit and stimulate the innate immune cells needed to 
fight of the infection. The innate immune cells recruited to the site of infection by the 
released chemokines are phagocytes and antigen-presenting cells (APCs) such as 
neutrophils, macrophages, and dendritic cells (DCs). Those cells work in conjunction with 
one another to kill the pathogen intracellularly by phagocytosis or extracellularly by 
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releasing DNA traps and other noxious cargo, present antigen to activate the adaptive 
immune response, and clear dead/dying cells via efferocytosis to prevent further 
inflammation (32-34). 
 Neutrophils are the first responders for any infection and while circulating they are 
constantly probing the endothelial cells of the vasculature searching for stimulated 
endothelial cells, which indicate sites of inflammation (35-38). The neutrophils then cross 
the endothelial barrier and becomes activated while making its way to the site of infection 
by following a chemoattractant gradient (39, 40). During the activation process, a number 
of pattern recognition receptors (PRRs) are activated, which also aids in the activation and 
induction of oxidative burst, degranulation is also initiated during PRR activation (41-45). 
This activation process during migration along the chemoattractant gradient allows for the 
neutrophil to be primed and ready to kill when it reaches the site of infection. Once at the 
site of infection the neutrophil has a few different antimicrobial weapons at its disposal. 
Phagocytosis, a receptor mediated process, that leads to the engulfment and internalization 
of bacteria and cellular debris into a phagosome is main mechanism utilized by neutrophils 
to clear pathogens (38, 46, 47). After entrapment of the pathogen inside the phagosome, 
the phagosome must undergo a maturation process in order to kill the pathogen. During 
that maturation process, granules filled with antimicrobial peptides, that aid in the killing 
of the pathogen, fuse to the phagosome (48). These granules also contain components of 
the NADPH oxidase machinery in its membrane, which is required for oxidative burst and 
the production of reactive oxygen species (ROS) (49). The granules also fuse with the 
plasma membrane, releasing antimicrobial peptides into the milieu at the site of 
inflammation as well as bringing necessary components of the NADPH oxidase complex 
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to produce ROS. This creates an inhospitable environment for the invading pathogen, while 
also affecting other cells causing the production of neutrophil and monocyte 
chemoattractant and other immune mediators that can enhance the antimicrobial effect of 
other immune cells (38, 50-58). Besides killing the pathogen through phagocytosis and the 
release of granular content and production of ROS inside the phagosome as well as outside 
the plasma membrane, neutrophils are also able to release extracellular traps or NETs, that 
are composed of DNA, decondensed chromatin, histones, and granule proteins. These 
NETs ensnare the pathogen, preventing it from disseminating, and giving time for other 
immune cells to come along and remove it (59, 60). The exact mechanism of NET 
formation and whether it is an active form of cell death or something viable neutrophils 
can do is not completely understood and is currently an active area of research in our lab 
(38, 46, 61-66). ROS and the NADPH oxidase complex are thought to be essential 
components of NETosis, though some reports, including ours indicate that it may depend 
on the stimulus (61, 65-71). Other processes such as the Raf-MEK-ERK pathway and 
autophagy have been implicated in NET formation (65, 66, 72, 73). The studies on 
neutrophil functions, including NET formation, have been hampered by the short life span 
of these cells and a lack of proper cell lines that faithfully reproduce all neutrophil 
functions. Due to these reasons, even though neutrophils were first described in 1846, the 
NETs were only discovered in the past two decades, indicating that there is still more to 
learn about neutrophil function (59, 74). 
Another key aspect of any innate immune response leading to a pro-inflammatory response 
is the role of pattern recognition receptors (PRRs) on host immune cells. These receptors 
are essential in recognizing pathogen associated molecular patterns (PAMPs) as well as 
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damage associated molecular patterns (DAMPs) and initiating an inflammatory response. 
There are thought to be five families of PRRs. Those include Toll-like receptors (TLRs), 
C-type lectin receptors (CLRs), NOD-like receptors (NLRs), RIG-I-like receptors (RLRs), 
and AIM2-like receptors (ALRs). ALRs, NLRs, and RLRs are classified as unbound 
intracellular receptors and are found inside the cytoplasm, while TLRs and CLRs are 
classified as membrane bound receptors (75-78) (Figure 2). As relevant to my work, I will 
only describe TLR and CLR functions and signaling in the sections below. 
11 
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Figure 2.  The Four Major Classes of Pattern-Recognition Receptor and Their Most 
Important Ligands. 
The four classes are toll-like receptors (TLRs), C-type lectin receptors (CLRs), nucleotide-
binding oligomerization domain (NOD) leucine-rich-repeat (LRR)–containing receptors 
(NLRs), and retinoic acid–inducible gene I protein (RIG-I) helicase receptors. NLRs, the 
central components of the inflammasomes, are complex protein platforms that lead to the 
activation of caspase 1 and interleukin-1β processing. The most extensively studied 
inflammasomes are as follows: the NOD leucine-rich-repeat and pyrin domain–containing 
protein 3 (NLRP3) inflammasome, activated by bacterial and fungal pathogen-associated 
molecular patterns; the NLR family caspase recruitment domain–containing protein 
(CARD) 4 (NLRC4) inflammasome, activated during intracellular bacterial infections by 
flagellin; and the absent in melanoma 2 (AIM2) inflammasome, activated by double-
stranded (ds) DNA. ASC denotes apoptosis-associated speck-like protein containing a 
CARD, HIN hematopoietic interferon-inducible nuclear protein, IRF3 interferon 
regulatory factor 3, LPS lipopolysaccharide, MAL myelin and lymphocyte protein, MDA5 
melanoma differentiation-associated protein 5, MR mineralocorticoid receptor, MyD88 
myeloid differentiation factor 88, NF-κB nuclear factor-κB, NLRC4 NLR family CARD-
domain–containing protein 4 (also known as IPAF), ss single-stranded, SYK spleen 
tyrosine kinase, TRAM TRIF-related adaptor molecule, and TRIF toll-like–receptor 
adaptor molecule.  Reproduced with permission from the New England Journal of 
Medicine, Copyright Massachusetts Medical Society (78). 
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TLRs are the most well characterized PRR. There are 10 TLRs expressed in humans and 
12 in mice. The localization and signal transduction pathway for each has been elucidated, 
while the major ligand for everyone, except TLR 10, is known (33, 76). TLRs signal 
through two main signal transduction pathways, the MyD88 dependent pathway and the 
TRIF dependent pathway. Only TLRs 3 and 4 signal through the TRIF pathway, but TLR4 
is unique in that it can also signal through the MyD88 pathway. Signaling through the 
MyD88 dependent pathway begins with MyD88 forming a complex with IRAK4 and 
IRAK1. The IRAK complex acts on TRAF6, which in turn polyubiquitinates TAK1 to 
activate it. TAK1 activation in turn leads to the activation of two pathways, the IKK 
complex NF-κB pathway and the MAPK pathway. Those pathways lead to induction of 
pro-inflammatory gene expression and release of pro-inflammatory cytokines. Activation 
of the TRIF dependent pathway begins when TRIF interacts with TRAF6 and TRAF3. 
TRAF6 then recruits RIP-1 kinase in order to activate TAK1 and the NF-κB and MAPK 
pathways. TRAF3 on the other hand interacts with TBK1, IKKi, and NEMO to 
phosphorylate IRF3, thereby activating it. Activated IRF3 forms a dimer and induces the 
expression of type I INF genes in the nucleus. Activation of either MyD88 or TRIF 
pathways leads to the activation of transcription factors AP-1, IRF3, and NF-κB, which 
causes the release of pro-inflammatory cytokines such as IL-1β, IL-6, IP-10, INF-γ, and 
TNF-α (34, 77-80) (Figure 3). 
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Figure 3. Principles in TLR signaling. 
TLR4 activates both the MyD88-dependent and MyD88-independent, TRIF-dependent 
pathways. The MyD88-dependent pathway is responsible for early-phase NF-κB and 
MAPK activation, which control the induction of proinflammatory cytokines. 
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Figure 3 cont. Principles in TLR signaling. 
The MyD88-independent, TRIF-dependent pathway activates IRF3, which is required for 
the induction of IFN-β- and IFN-inducible genes. In addition, this pathway mediates late-
phase NF-κB as well as MAPK activation, also contributing to inflammatory responses. 
Reproduced with permission from the American Society of Microbiology (34). 
 
 The other membrane bound PRR, CLRs belong to a broader family of receptors and have 
not been as well characterized as TLRs have. There are 17 different groups of CLRs based 
on the structure of the carbohydrate recognizing domain (CRD) (81). Given the number of 
different groups of CLRs, it is no surprise that the family includes both secreted and 
transmembrane proteins. CLRs are most often expressed on myeloid cells and have a wider 
range of functions than TLRs. CLRs have been shown to play a role in PAMP recognition, 
phagocytosis, cytokine and chemokine production, antigen presentation, and development 
of the adaptive immune response (82-85). In addition to pathogen recognition, CLRs have 
been shown to be receptors for self-ligands and to play a role in maintaining homeostasis. 
For example, Mannose receptor (MR) has been shown to play a role in the clearance of 
apoptotic cells via efferocytosis (86, 87). Likewise, soluble CLR, Galectin-3 (Gal3) has 
been shown to play a role in the clearance of apoptotic neutrophils via efferocytosis (88). 
Work from our lab showed that galectin-3 and -9 can act as DAMPs to increase 
inflammatory response during bacterial pneumonia (89, 90). Other CLRs, such as LOX-1, 
MGL1, and DEC-205, recognize apoptotic cells, but have not been further implicated in 
homeostatic process that is efferocytosis (91-93). Further, soluble lectins such as 
Collagenous lectins (Collectins) act as opsonins along with complement proteins in order 
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to opsonize and take up apoptotic cells (94-97). Beyond just apoptotic cell recognition, 
CLEC-2, DC-SIGN, and MGL have been implicated in tumor immune surveillance by 
binding tumor antigens (98-101). The CLR Mincle (Clec4e), is a sensor for SAP-130, an 
alarmin released by necrotic cell bodies (102, 103). We and others have shown its role in 
various disease conditions (65, 66, 104-109). Soluble CLRs, Gal3 and Gal9, have both 
been characterized as alarmins (89, 90).   
Given the numerous ways in which CLRs play a role in inflammation and homeostasis, it 
is important to understand what role CLRs play in sepsis development and neutrophil 
function. These topics have been researched to some extent with 195 and 430 search results 
for sepsis and C-type lectins or neutrophils and C-type lectins respectively in PubMed as 
of June 2017. While those search results indicate that research is being done on this topic, 
given the sheer number of CLRs it is important to continue to characterize their function 
in sepsis development. Doing so will not just increase our understanding on CLRs and their 
function, but highlight new therapeutic targets in the treatment of sepsis. 
Resolution of Inflammation: Efferocytosis 
A vital part of any infection is the clearance of the infiltrating immune cells that fought the 
infection in order to achieve a state of homeostasis. Failure to efficiently clear the 
infiltrating neutrophils at the site of infection can lead to further inflammation. Apoptotic 
neutrophils can undergo secondary necrosis, causing the release of damage associated 
molecular patterns (DAMPS) and pathogen associated molecular patterns (PAMPS). The 
release of those pro-inflammatory markers will help drive further inflammation, 
contributing to the development of sepsis (110-114). The process of efferocytosis involves 
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clearing of apoptotic cells by professional phagocytes such as macrophages and immature 
dendritic cells. Efferocytosis plays a vital role in controlling inflammation, by clearing 
pathogens not destroyed through phagocytosis (115) in addition to preventing the release 
of pro-inflammatory mediators from necrotic cells (110). Upon engulfment of dead cells, 
the efferocytic phagocytes undergo phenotypic changes that leads to the production of 
TGF-beta and IL-10, anti-inflammatory mediators, which are able to shut down the 
inflammatory immune response and prevent further cellular influx (112, 116-120). Not 
surprisingly, defects in the efferocytic process has been associated with development of a 
variety of inflammatory diseases including atherosclerosis, cystic fibrosis, and chronic 
obstructive pulmonary disease (COPD) (121). Interestingly, products released by necrotic 
neutrophils during infection and inflammation inactivate anticoagulants such as activated 
protein C, which can further drive sepsis development by deregulating the coagulation 
system, causing vascular injury, and contributing to organ failure and death (122).  Given 
that sepsis is characterized by massive cell death culminating in organ failure, one might 
speculate that a deregulation of efferocytosis causing inefficient neutrophil turnover might 
lead to the development of sepsis. A PubMed search for “sepsis and efferocytosis” turned 
up only 10 articles as of June 2017.  Of those 10 articles, 3 are reviews that only speculate 
on the effect efferocytosis has on the development of sepsis. 3 of the other 7 articles deal 
directly with the efferocytosis of neutrophils, while the 4 identify different ways to 
modulate efferocytosis. This clearly highlighted that this field is highly understudied. 
Efferocytosis and the resolution of inflammation is a complex and well-orchestrated 
process. The first step in efferocytosis is the recruitment of the phagocytic cells by the 
release of "find me" signals by the apoptotic cell, which creates a gradient that leads the 
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phagocytic cell to migrate to the apoptotic cell. Once the phagocytic cells are in the vicinity 
of the apoptotic cells, they are able to recognize and bind a number of different "eat me" 
signals. "Eat me" signal binding to the "eat me" signal receptor activates a signaling 
pathway leading to Rac activation, which in turn causes to actin polymerization and 
eventual cytoskeletal rearrangement that is required for internalization and clearance (110, 
123-125) (Figure 4). 
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Figure 4. Immunomodulatory roles of efferocytosis signals.   
Depiction of the tree key stages of efferocytosis (dashed boxes) with detailed illustrations 
showing some of the known signaling molecules/pathways relevant to immune modulation 
for each of the three stages. The lower table indicates some of the key effects of these 
efferocytosis signaling mechanisms on the following: immune signaling in phagocytes, 
production of immune mediators, and some of the prominent immune outcomes of the 
indicated molecules/pathways. Arrows in the table indicate whether signaling via these 
pathways generally increases of decreases the effects listed. Please note this diagram 
represents only a portion of the efferocytosis signals and their immunoregulatory effects 
that have been described. MMP, matrix metalloprotease; PS, phosphatidylserine (PtdSer); 
RTK, receptor tyrosine kinase. Reproduced with permission of The American Association 
of Immunologist. Copyright 2017. The American Association of Immunologist, Inc. (126). 
 
While the general process of efferocytosis is straight forward, there are numerous factors 
that play a role, many of those factors are not fully understood or not even identified yet 
(110, 123). There are a few different "find me" signals, lipids such as 
lysophosphatidylcholine (LPC), which binds to G-protein-coupled receptor G2A (127) or 
S1P that too binds G-protein-coupled receptors (123, 128). Other "find me" signals include 
a classical chemokine Fractalkine (CXC3CL1) (129) and nucleotides such as ATP and 
UTP that bind the P2Y2 receptor on the phagocytic cell (130). Several "eat me" signals, 
including ICAM3 (110, 123, 131), thrombospondin, compliment C1q, Calreticulin (110, 
123), changes in glycosylation (132), and the most well characterized one is 
phosphatidylserine (PtdSer) (110, 123, 133, 134). Most of the known and characterized 
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"eat me" signal receptors, such as TIM1&4, BAI-1, Sabilin-2 bind PdtSer (110, 123, 135-
140). CD14 binds to the "eat me" signal ICAM3, while CD36 with the help of integrins 
binds to thrombospondin (123). The signaling mechanisms activated by "eat me" signal 
binding to receptor leading to apoptotic cell internalization are not well known. There are 
two semi characterized pathways, both of which lead to the activation of Rac, which is 
required for actin polymerization and cytoskeletal rearrangement needed for apoptotic cell 
internalization and clearance (110, 123, 124). The CrkII–Dock180–ELMO pathway is the 
better characterized pathway of the two. Dock180 and ELMO complex together in order 
to form an unconventional guanine nucleotide exchange factor complex, needed to activate 
Rac (Figure 5).  
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Figure 5. Signaling pathways elicited by three PtdSer recognition receptors. 
Binding of the apoptotic cell to the phagocyte triggers signaling pathways. BAI1 is a 7-
transmembrane receptor that directly binds the PtdSer on the surface of an apoptotic cell, 
resulting in the recruitment of the Engulfment and cell motility (ELMO)/Downstream of 
Crk (DOCK) complex, which functions as a guanine exchange factor for the small 
GTPase Rac. Rac activation promotes actin cytoskeleton remodeling required for the 
engulfment of the apoptotic corpse. Integrins αVβ3 or αVβ5 and the Tyro Axl Mer (TAM) 
family receptors bind apoptotic cells indirectly, via PtdSer-bound bridging molecules 
MFG-E8, Gas6 or ProteinS, resulting in the activation of the focal adhesion kinase (FAK) 
and contributing to the activation of Rac. TAM receptors are tyrosine kinases that also 
activate cell signaling pathways involving the kinases Src and phosphatidylinositol-3-
kinase (PI3K) and phospholipase C (PLC). TIM4 functions as a tethering receptor 
bringing the apoptotic cell in contact with signaling engulfment receptors, and signal 
through co-receptors. The extent of the connection between the signals elicited by 
different engulfment receptors awaits further characterization. Reproduced with 
permission from Nature Reviews Immunology. Permission # 4126831301692 (141). 
 
In order to activate Rac, Dock180 and ELMO, sometimes CrkII, are recruited to the cell 
membrane upon "eat me" signal ligation to the carboxyterminal of the receptor (110, 123, 
140, 142). The second pathway recruits the adapter protein GULP, the molecular 
components in that pathway are not fully understood (110, 123). Efferocytosis is a complex 
process with numerous components that could easily become deregulated and disrupt the 
resolution of inflammation and return to homeostasis, which would drive the development 
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of chronic inflammation and eventually lead to sepsis. Therefore, it is a promising area of 
research in regards to understanding the development of sepsis and how a beneficial host 
response aimed at restoring the body to homeostasis could lead to massive inflammation 
and tissue destruction if deregulated. 
Bacteria Fighting Back 
In order to survive inside the host, bacteria have developed numerous ways by which to 
evade the host immune response. The host immune response is initiated when the pathogen 
is recognized by various pattern recognition receptors (PRRs) on the innate immune cell 
as described above. This activates the innate immune response, leading to an inflammatory 
response in order to kill the invading pathogen. The pathogen can be killed directly via 
phagocytosis and phagolysosomal fusion or indirectly by being trapped via NETosis or 
cleared after escaping the phagosome via efferocytosis. Below are just a few cases to 
highlight the many ways bacteria are able to evade host recognition, engulfment, and 
killing. One of the first steps in fighting of the infection is recognition of the pathogen and 
subsequent release of chemokines and cytokines meant to recruit phagocytic cells to the 
site of infection. Streptococcal species of bacteria produce streptolysin, which is able to 
suppress neutrophil chemotaxis and even kill phagocytes (143). Other bacteria such as 
Treponema pallidum, the causative agent of syphilis, cloak themselves in host protein in 
order to evade phagocytosis (144, 145). Once the pathogen is recognized and phagocytic 
cells recruited to the site of infection the next step in clearing the pathogen is to 
phagocytosis. Some bacteria such as Klebsiella pneumoniae produce capsules that prevent 
phagocytic engulfment (146-148). While others such as Pseudomonas aeruginosa and 
Yersinia enterocolitica utilize type III secretion systems to inject effector molecules into 
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the host to prevent phagocytosis (149, 150). If the host is unable to phagocytose and kill 
the bacteria, other host defense weapons are deployed. For example, neutrophils have the 
ability to produce extracellular traps (NETs) by spewing out their DNA and histones as a 
way to trap extracellular pathogens, prevent their dissemination, and allow for them to be 
cleared by other means (151). Several pathogens have devised mechanisms to escape 
entrapment or killing by NETs. Staphylococcus aureus produces a nuclease which is able 
to degrade NETs and allow S. aureus to escape (152). In addition to there, several bacterial 
pathogens are able to survive inside the phagocyte upon phagocytosis, whether that be in 
the phagosome, the phagolysosome, or in the cytoplasm. Rickettsiae for example, escapes 
from the phagosome to survive in the cytoplasm, through the use of bacterial enzyme 
phospholipase A (153). Listeria monocytogenes also uses its own hemolysin enzyme 
listeriolysin O to escape the phagosome (154). Mycobacterium tuberculosis on the other 
hand produces sulfatides that arrest the phagosome and prevent phagosome-lysosome 
fusion (155). The bacterium Salmonella typhimurium has the ability to adapt to extremely 
low pH values and survive within phagoslysosome (156). Despite the pathogens best 
efforts to survive inside the phagocyte, the host is still able to clear the pathogen through 
efferocytosis. As mentioned above Mycobacterium tuberculosis is able to arrest the 
phagosome, evade the host response, replicate inside the cell, and disseminate when the 
cell become necrotic over time. The host can clear the bacteria via the uptake of infected 
apoptotic phagocytes by the process of efferocytosis. The M. tuberculosis is already 
compartmentalized inside an arrested phagosome and is unable to prevent lysosomal fusion 
to the new phagosome, thus killing the bacteria (157). Pseudomonas aeruginosa is also 
cleared through efferocytosis. In this case the bacterium binds to apoptotic cells or 
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apoptotic bodies and then internalized and killed via efferocytosis (158). Just as with 
phagocytosis, bacteria have found a way to hijack efferocytosis. Listeria monocytogenes 
can escape the phagosome with its listeriolysin O toxin and then hijack host actin regulation 
via its ActA protein. From there it is able to escape the host cell in a membrane-derived 
vesicle covered with exofacial phosphatidylserine (PS). That vesicle is recognized by the 
PS-binding domain TIM-4 and is then efferocytosed into a new cell, where it can continue 
to disseminate from cell to cell (159). S. aureus on the other hand takes a different approach 
to exploit efferocytosis. It acts on neutrophils to upregulate the expression of “don’t eat 
me” signal CD47 on the cell surface in order to prevent the efferocytosis of the infected 
cell as well as driving the cell away from apoptosis and toward necroptosis (160). This 
account of host defense strategies and the bacterial evasion mechanisms briefly highlights 
the tug of war between the host and the pathogen and describes some of the mechanisms 
by which bacteria are able to survive and cause disease. While several advances have been 
made on different bacterial strategies used to evade phagocytosis or survive inside the 
phagocyte (161-164), the same cannot be said about how bacteria manipulate efferocytosis. 
There are only 83 published articles on efferocytosis and bacteria as of June 2017. Of those, 
only one study describes the effect bacteria has on neutrophils to inhibit their efferocytosis 
(160). Bacterial manipulation of efferocytosis is a promising area of research that is only 
just beginning to be explored. This research could identify new targets for antimicrobial 
therapies as well as identify novel virulence factors in bacteria. Our work utilizing 
Klebsiella pneumoniae (KPn) to induce pneumonic sepsis in mice allows us to not only 
look at the role C-type lectin receptors (CLRs) play in pneumonic sepsis; it allows us to 
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study the pathogenicity of KPn and the virulence mechanisms that it utilizes to subvert host 
defenses in order to become one of the leading causes of sepsis (12, 17, 18). 
Animal Model of Sepsis 
Three murine models of sepsis have been described to recapitulate the disease development 
in humans. The endotoxemia model, uses administration of exogenous toxins such as 
bacterial lipopolysaccharide (LPS) to induce sepsis like symptoms in mice. It can only 
mimic some of the pathophysiological alterations seen in sepsis patients, but is utilized 
owing to its ease and reproducibility. This model shows a rapid increase in systemic 
cytokine levels over a period of 8 hours, peaking between 1.5 to 4.5 hours post injection 
(165). Unfortunately, this differs from clinical manifestations of sepsis where there is 
prolonged systemic cytokine levels that is orders of magnitude lower than what is seen in 
the endotoxicosis model. Also, the therapeutic targets identified using this model have 
proven ineffective in human clinical trials, strongly suggesting that this model while 
convenient and reproducible may not be the most relevant model to use in regards to human 
disease (165-172).   
The second model is a breach in the endogenous protective barriers, such as cecal ligation 
and puncture (CLP) and colon ascendens stent peritonitis (CASP) models. These models 
were once considered the “gold standard” of animal sepsis models because they were able 
to reproduce a number of key hallmarks of sepsis in mice, such as hyperinflammation, 
bacteremia, systemic organ damage, and mortality. However, these models induce 
polymicrobial sepsis, while relevant to some forms of sepsis is not relevant to hospital-
acquired pneumonias, which are usually caused by a single bacterial species. While these 
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models replicate some aspects of sepsis, they do not provide insight into the host pathogen 
response mechanisms underlying sepsis (165-173).  
The third model is the live bacterial infection model, which includes the pneumosepsis 
model. This model focuses on one of the leading causes of sepsis, pneumonia, accounting 
for almost 50% of all cases (2, 12). This model is able to reproduce the hallmarks of sepsis 
seen in humans such as hyperinflammation, bacteremia, systemic organ damage, and 
mortality. Importantly, this model uses only a single pathogen, which is more frequently 
the case in human sepsis, unlike the CLP and CASP models that induce polymicrobial 
sepsis (12). That allows examination of the host pathogen interaction mechanisms. In our 
lab, we utilize the pneumoseptic model of Klebsiella pneumoniae (KPn) infection. This 
model focuses on pulmonary bacterial infection, which is a leading cause of sepsis (2, 12, 
14, 172). Intranasal delivery of this pathogen in WT (C57/BL6) mice produces major 
characteristics of sepsis i.e., hyperinflammation, bacteremia, systemic organ damage, and 
mortality. 
Klebsiella pneumoniae (KPn), is a Gram-negative, nonmotile, encapsulated, bacterium that 
belongs to the Enterobacteriaceae family of bacteria (174-176). Members of that family, 
including Klebsiella species and E. coli are the leading cause of sepsis (12, 17, 18). KPn 
resides all over the environment and readily colonizes human mucosal surfaces (174, 175). 
Pneumonias and Urinary Tract Infections are the primary infections caused by KPn. This 
opportunistic pathogen causes both community-acquired pneumonias (CAP) and hospital-
acquired pneumonias (HAP), which are the leading cause of mortality among nosocomial 
pneumonias  (176-179). Approximately 12% of all HAPs are due to KPn, while 
approximately 4% of CAPs are caused by KPn (180-182). Interest in KPn has increased in 
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recent years due to the emergence of multidrug resistant and hypervirulent strains. This is 
worrisome given the number of HAPs caused by KPn and how it is more likely that the 
KPn will be multidrug resistant due to many of those patients having already been treated 
with antibiotics (177, 183, 184).  
KPn has four well characterized virulence factors, which are capsule, lipopolysaccharide 
(LPS), fimbriae, and siderophores. It uses these virulence factors to evade early host 
immune responses (176, 185). The capsule is a protective polysaccharide coating that 
covers the bacterium and is thought to be necessary for virulence. There are 78 serotypes 
of the K antigen that makes up the capsule, of those 25 make up 70% of all isolated strains, 
with K1 and K2 being associated with the most virulent strains. K1 and K2 strains are more 
virulent due to a lack of mannose in their capsules. The lack of mannose means no mannose 
receptor binding, which inhibits efficient phagocytosis and downstream signaling (146-
148, 186-190). The capsule of KPn prevents opsonization and phagocytosis of the bacteria 
by neutrophils and other phagocytic cells (191, 192). The capsule also protects the baterium 
from complement mediated killing as well as other antimicrobial peptides. Early 
inflammatory response is also suppressed due to the capsule and its ability to inhibit TLR2 
and TLR4 signaling. Inhibition of those PRR signaling pathways, removes key aspects of 
the innate immune response, thereby reducing the early inflammatory response to the 
pathogen when compared to non-capsulated bacteria (146, 192, 193). It is clear from these 
examples that the capsule is an essential tool for the bacteria to subvert and suppress the 
early host immune response. 
KPn is a Gram-negative bacterium and as such the endotoxin LPS is a part of its cell 
membrane. LPS is both detrimental and beneficial to KPn virulence. KPn LPS has 9 O 
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antigens, with O1 being the most common. Full-length O antigen on LPS prevents 
complement mediated killing by hiding complement activators on the bacterial cell surface 
(192, 194-196). The lipid A portion of LPS is recognized by the pattern recognition 
receptor (PRR) TLR4, which leads to the production of cytokines and chemokines as well 
as cellular recruitment (197). Some KPn strains with particular K antigens are able to mask 
their LPS inside the capsules, which dampens TLR4 signaling (196). KPn also modulates 
its LPS, like other bacteria, such as Yersinia pestis, so that it is no longer recognized by 
TLR4 (198, 199). Interestingly, Lipid A along with the core polysaccharide of LPS can 
resist phagocytosis in the lungs by alveolar macrophages (200). LPS is an endotoxin and 
activates the innate immune system through TLR4 to recruit cells via the release of 
chemokines and cytokines. It also plays a protective role on the bacterial surface by 
preventing phagocytosis and complement mediated killing. 
KPn has both type 1 and type 3 fimbriae as virulence factors. These fimbriae are important 
for adhesion and biofilm formation. Type 1 fimbriae are thin, thread like protrusions on the 
cell surface and are expressed biased on environment. They are expressed while the 
bacteria is in the urinary tract, but not the GI tract or lungs (201, 202). Type 3 fimbriae on 
the other hand are helix like filaments, but similar to type 1 fimbriae are not needed for GI 
track infection or virulence in the lungs. Type 3 fimbriae can bind tracheal cells and 
therefore assist KPn in the colonization of the lungs (203-205).  
Siderophores are used to acquire iron from the host and are essential for bacterial survival 
and virulence. They are secreted and have a higher affinity for iron than host transport 
proteins. KPn has a number of different siderophores, such as enterobactin, yersiniabactin, 
salmochelin, and aerobactin. More common KPn strains usually have only enterobactin as 
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its siderophore, while more hypervirulent strains also utilize the siderophores 
yersiniabactin, salmochelin, and aerobactin (206-210). Other possible virulence factors in 
KPn have been identified, but have yet to be fully characterized (176). 
KPn virulence factors described above help the bacteria subvert and suppress the early 
inflammatory host response, allowing the bacteria to establish an infection and survive.  
These virulence factors have been well characterized and the ways in which they aid in 
KPn pathogenesis are known. With the emergence of multidrug resistant and hypervirulent 
strains of KPn over the past couple of decades, it is essential to identify new virulence 
factors and pathogenic mechanisms that can be targeted for new therapies against KPn 
infection. 
Outline of dissertation 
Sepsis is a complex immune disorder, the roles in which CLRs and bacterial pathogenesis 
play in the development of sepsis is understudied. The aim of this dissertation is to study 
the role two particular CLRs, Macrophage Galactose Type Lectin-1 (MGL1) and Mincle 
(Clec4e), play in pneumonic sepsis as well as identity novel pathogenic strategies used by 
KPn, a causative agent of pneumonic sepsis, to establish an infection in the host. In the 
following chapters, we show that CLRs play an important protective role in KPn induced 
pneumonic sepsis by regulating neutrophil turnover and that the pathogen employs a 
strategy to help overcome host defense mechanisms to successfully establish infection. 
In Chapter 2 the role of MGL1 in pneumonic sepsis will described. MGL1 has not been 
characterized in bacterial infections and disease pathogenesis to date. It is known to be 
expressed on macrophages and immature dendritic cells and play a role in recognition of 
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tumor antigens as well as apoptotic cells (100, 211, 212). Here we show that MGL1 is 
protective in KPn induced pneumonic sepsis and that protection is due to its role in 
neutrophil migration and turnover. Chapter 3 will focus on the protective role of Mincle 
during KPn induced pneumonic sepsis. Mincle is an activating receptor for damage-
associated and pathogen-associated molecular patterns, called DAMPs and PAMPs and 
can be expressed in neutrophils, macrophages, and dendritic cells. Most of the functional 
analysis of the receptor has been done in macrophages. Its role in chronic bacterial 
infections has been studied, but how it functions in acute pneumonic infections is not 
known (102, 109, 213-215). We show that in pneumonic infections leading to sepsis, 
Mincle plays a protective role via bacterial clearance mechanisms phagocytosis and 
NETosis in neutrophils.  
Chapter 4 transitions from the host response in pneumonic infection to bacterial pathogenic 
mechanisms used to establish infection. KPn, a causative agent of sepsis, has virulence 
factors that help it evade and suppress early host immune response (146, 191-196). Here 
we show a novel mechanism by which KPn modulates the route of cell death in infected 
neutrophils to inhibit efferocytosis of those infected cells, indicating another pathogenic 
mechanism KPn utilizes to evade the host response. Chapter 5 contains a summary along 
with a discussion of these new findings and conclusions in this dissertation. 
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Abstract 
C-type lectin receptors (CLRs), the carbohydrate recognizing molecules, orchestrate host 
immune response in homeostasis and in inflammation. In the present study we examined 
the function of macrophage galactose-type lectin-1 (MGL1), a mammalian CLR, in 
pneumonic sepsis, a deadly immune disorder frequently associated with a non-resolving 
hyperinflammation. In a murine model of pneumonic sepsis using pulmonary infection 
with Klebsiella pneumoniae (KPn), the expression of MGL1 was upregulated in the lungs 
of KPn infected mice and the deficiency of this CLR in MGL1-/- mice resulted in 
significantly increased mortality to infection than the MGL1-sufficient wild-type mice, 
despite a similar bacterial burden. The phagocytic cells from MGL1-/- mice did not exhibit 
any defects in bacterial uptake and intracellular killing and were fully competent in 
neutrophil extracellular trap formation, a recently identified extracellular killing modality 
of neutrophils. Instead, the increased susceptibility of MGL1-/- mice seemed to correlate 
with severe lung pathology, indicating that MGL1 is required for resolution of pulmonary 
inflammation. Indeed, the MGL1-/- mice exhibited a hyperinflammatory response, massive 
pulmonary neutrophilia and increase in neutrophil-associated immune mediators. 
Concomitantly, MGL1 deficient neutrophils exhibited an increased influx in pneumonic 
lungs of KPn infected mice. Together these results show a previously undetermined role of 
MGL1 in controlling neutrophilia during pneumonic infection thus playing an important 
role in resolution of inflammation. This is the first report depicting a protective function of 
MGL1 in an acute pneumonic bacterial infection.  
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Introduction 
Pattern recognition receptors (PRRs) activate innate immune responses upon detection of 
conserved pathogen motifs as well as self-molecules released during a pathological insult. 
Among the PRRs, the Toll-like receptor (TLR) family is the most characterized group of 
receptors known to be involved in activation and maturation of innate immune cells such 
as dendritic cells and macrophages, among others (216).  Another family of PRRs consists 
of transmembrane and soluble C-type lectin receptors (CLRs), which have selective 
affinity for self and non-self glycan motifs in a Ca2+-dependent manner  (217). Due to their 
abundant expression on sentinel cells of innate immune system that contribute to 
inflammation and maintenance of immune homeostasis, CLRs act as key sensors of tissue 
integrity and pathological insult and play a central role in orchestrating immune responses 
(218).  
Macrophage galactose-type C lectin 1 (MGL1) is a type 2 transmembrane CLR expressed 
on macrophages and immature dendritic cells with a binding specificity for galactose 
and/or its monosaccharide derivative, that are abundantly expressed on tumor antigen 
MUC1 as well as self-antigens such as gangliosides (211).  Not surprisingly, MGL1 is 
included in the family of scavenger receptors along with macrophage mannose receptor 
(212) that plays a role in recognition of tumor antigens and apoptotic cells (93, 100). 
Although this CLR can bind antigens from Neisseria gonorrhoeae (219), Campylobacter 
jejuni (220) and Bordetella pertussis (221), its role in overall disease pathogenesis is 
unknown. An anti-inflammatory function of this CLR in colitis via its interaction with 
commensal bacteria has been reported (222). However, the current knowledge of MGL1 
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function in infectious diseases, particularly the pathogenesis of pneumonia and sepsis is 
virtually non-existent.  
Sepsis is a deadly disorder characterized by a systemic hyperinflammation resulting usually 
from an infectious insult. An estimated 20-50% of the 750,000 sepsis and severe sepsis 
patients die in the US owing to the lack of effective treatment strategies (2).  Infections of 
the lung and the respiratory tract are the main causes of severe sepsis, and 41% of these 
infections are due to Gram-negative bacteria (223-225). Nosocomial infections with 
Klebsiella pneumoniae (KPn) account for 5-20% of Gram-negative sepsis cases (223, 225). 
KPn-induced lung infection is a clinically relevant animal model of sepsis and a better 
understanding of this model may help to increase the knowledge about sepsis 
pathophysiology (169). Additionally, emergence of multidrug resistant isolates of KPn in 
clinical settings is a serious health concern. In this scenario an understanding of the 
functioning of host innate immune components that influence the outcome of KPn 
pneumonia might provide targets for modulation of host immune system in a beneficial 
manner. 
In this study we examined if MGL1 plays a role in orchestrating host defense against KPn 
pneumosepsis. Indeed, our results suggest that MGL1-mediated responses are required for 
the resolution of pneumonia and an increased susceptibility of MGL1-/- mice correlates with 
the increased inflammatory response and with massive accumulation of neutrophils in the 
lungs of infected mice, despite similar bacterial burden. These results identify for the first 
time, a protective role of MGL1 in regulation of neutrophil influx and inflammatory 
response against pneumonic KPn sepsis.  
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Materials and Methods 
Bacterial strains and Mice 
The KPn (ATCC strain 43816) were grown to log phase in LB medium at 37oC. All in-
vivo experiments were performed using 6-8 weeks old female wild-type C57BL/6 (WT) or 
MGL1-/- mice on same background obtained from JAX mice (Jackson Laboratory), and 
bred in the animal facility of the University of North Dakota. The animals were used 
according to institutional and federal guidelines.  
Infection of Mice, survival and bacterial burden   
Mice were anaesthetized with a mixture of 30mg/ml ketamine and 4 mg/ml xylazine in 
PBS and were infected intranasally with 3.0 x 104 CFUs in 20ul of saline, of KPn or with 
20 µl of saline alone. Survival of the mice was recorded for up to 2 weeks post-infection 
(p.i.). Death was recorded as infection induced mortality. Mice displaying severe signs of 
distress (labored breathing, non-responsiveness to cage tapping, failure of grooming and 
feeding) were humanely sacrificed and also recorded as infection induced mortality. In 
some experiments, the mice were euthanized at indicated times p.i. and blood, lungs and 
liver were aseptically homogenized in cold PBS with CompleteTM protease inhibitor 
cocktail (Roche Diagnostics, Germany). For the bacterial burden analyses, serially diluted 
homogenates and blood were plated on LB agar and incubated at 37oC overnight.  
Quantitative real-time PCR 
Total RNA from lungs of infected and mock control mice harvested at various times p.i. 
was extracted using Trizol reagent (Invitrogen) according to the manufacturers' 
instructions. Real-time PCR analysis was performed using SYBR green (Applied 
Biosystems, CA, USA) to measure the MGL1-specific mRNA by using specific primers 
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(sense) 5'- 5′-TCTCTGAAAGTGGATGTGGAGG-3′ and (anti-sense) 5′-
CACTACCCAGCTCAAACACAATCC-3′ as described by us (226). The target gene 
expression levels were normalized to levels of the house keeping 18S gene in the same 
sample. Expression of MGL1 in infected samples was determined as fold change over that 
in control samples as calculated by using the formula 2−(ΔΔCt). 
Multi-analyte profile analysis 
The lung homogenates were prepared as described for the bacterial burden analysis above 
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants were 
immediately frozen at -80o C. The biomarker levels in lung homogenates were determined 
commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing a multiplexed 
analysis. 
Histological and Immunofluorescence analysis 
For histological analysis, frozen lung tissues were processed as previously described (227, 
228). Serial horizontal sections (10 µm thick) of frozen lung tissues thus obtained were 
stained with hematoxylin and eosin for pathological analysis as previously described (229, 
230) . For Immunofluorescence staining, the frozen lung tissue sections were stained for 
the detection of MGL1, using an affinity purified anti-mMGL1/CD301 goat IgG (R&D 
Systems, Minneapolis, MN) and visualized with Alexa Fluor® 546 donkey anti-goat IgG 
(Life Technologies, Grand Island, NY). The images were acquired using a Nikon eclipse 
80i upright microscope (Nikon Corporation, Tokyo, Japan) with an attached cooled RTke 
Spot 7.3 three spot color camera (Diagnostic Instruments Inc., Sterling Heights, MI). The 
images were processed and analyzed using Adobe Photoshop 7.0 software (Adobe, 
Mountain View, CA). 
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Flow Cytometry  
Lungs cells were harvested from mice at 3 days p.i. and processed as previously described 
by us (227, 228, 231). Cells types in the lungs were quantified by staining with Pacific 
BlueTM anti-mouse CD11b (Clone M1/70), APC-Cy7 anti-mouse CD11c (Clone N418), 
FITC anti-mouse CD19 (Clone 6D5), Brilliant Violet 570 anti-mouse CD3 (Clone 17A2), 
APC anti-mouse Ly6G  (Clone 1A8), PerCP/Cyc5.5 anti-mouse Ly6C (Clone HK1.4), PE-
Cy7 anti-mouse F4-80 (Clone BM8) antibodies (Biolegend, San Diego, CA), and PE anti-
mouse TCR β (Clone H57-597) antibody (Becton Dickinson Pharmingen, San Jose, CA). 
Enumeration of neutrophils by flow cytometry (using a BD LSR II, Becton Dickinson, San 
Jose, CA) was done by quantitating Ly6G+CD11b+ cells stained with Pacific BlueTM anti-
mouse CD11b (Clone M1/70) and APC anti-mouse Ly6G (Clone 1A8) antibodies 
(Biolegend, San Diego, CA). FlowJo (Tree Star) software was used to analyze all data.  
Bacterial phagocytosis and killing by neutrophils and macrophages 
Bacterial phagocytosis of WT and MGL1-/- neutrophils and macrophages was assessed by 
plating on LB media, incubating at 37°C overnight, and counting colonies. For this, 
peritoneal neutrophils from C57BL/6 and MGL1-/- mice were isolated using an established 
method of thioglycollate-induced peritonitis. Sterile 4% thioglycollate was injected in 
peritoneal cavity of mice and neutrophils enriched 16-18h following the injection were 
isolated. Five x105 Neutrophils were incubated with KPn (MOI 50) for 1 hour to determine 
bacteria uptake and 3 hours to determine bacteria killing. After 1h the neutrophils were 
washed two times with warm PBS and one time with RPMI before adding 2µg/mL 
gentamicin in RPMI (Gibco) with 10% FBS for the remaining 2h (for the 3h samples) and 
for 15 minute for the 1h samples. The cells were washed extensively with warm PBS before 
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lysing with 0.1% TritonX100. Serial dilutions of the lysates were plated on LB media 
overnight at 370C before colonies were counted.  
Bone marrow was isolated from wild-type and MGL1-/- mice and the cells were 
differentiated to macrophages as previously described (232). On day 6 of culture, 3x105 
macrophages were plated in 24-well flat bottom plates and were infected with KPn (MOI 
50) for 1 hour to determine bacteria uptake and 3 hours to determine bacteria killing as 
described above. 
Neutrophil Extracellular Traps 
For detection of neutrophil NETs in-vivo, the bronchoalveolar lavage (BAL) was 
performed in WT and MGL1-/- mice at 3dp.i. (66). The lavage cells were cytocentrifuged 
on glass slides and were stained with Sytox Green (Molecular Probe, Eugene, OR) to 
visualize NETs. The percent NET formation was quantitated by dividing the number of 
NET-forming neutrophils by total number of cells in 8-10 random microscopic fields and 
multiplying the values by 100. The experiment was repeated 3 times.  
Neutrophil Adoptive Transfer 
Adoptive transfer of bone marrow neutrophils was performed by methods previously 
described with modifications (233-235). Briefly, bone marrow neutrophils were isolated 
from WT and MGL1-/- mice by gradient separation. Purified neutrophils (~80% purity 
determined by flow cytometry) were labeled with CellTracker Orange CMTMR (Life 
technologies) or CellTracker Green CMFDA (Life technologies) at 37°C for 10 minutes. 
Labeled cells were mixed in 1:1 ratio using 2x106 each group and then injected 
intravenously via tail vein into WT and MGL1-/- mice that had been infected with 3.0 x 104 
CFUs of KPn intranasally 24h prior. Lungs were harvested 2h after the tail vein injections 
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and processed for flow cytometry as described above. Adoptively transferred neutrophils 
recruited to the lungs were enumerated using LSR II flow cytometer and analyzed using 
FlowJo software (BD Biosciences, San Jose, CA). Relative recruitment of WT and MGL1-
/- neutrophils was calculated as the ratio of indicated populations.  
In-vivo Efferocytosis 
Peritoneal neutrophils from WT and MGL1-/- mice were isolated and labelled with 
Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit 
from Invitrogen) per manufacturer’s instructions. CFSE-labelled WT and MGL1-/- 
neutrophils were suspended in complete RPMI and 35uL/3.5x106 cells were administered 
intranasally into mice anaesthetized using a mixture of 30mg/ml ketamine and 4 mg/ml 
xylazine in PBS. Lungs were lavaged as described by us (65, 236) 2 hrs after the instillation 
and alveolar macrophages analyzed by flow cytometry using PE-Cy7 conjugated anti-
F4/80 and APC conjugated anti-Ly6G antibodies (BioLegend, San Diego, CA).  
Efferocytic uptake by macrophages was quantitated by flow cytometry to enumerate Ly6G- 
F4/80+ CFSE+ cells. All other statistical analyses were performed using the Student t test 
(SIGMA PLOT 8.0, Systat Software, San Jose, CA). 
Statistical Analysis 
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test; 
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses 
were performed using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose, 
CA). 
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Results 
MGL1 expression in mouse lungs during pneumonic KPn infection  
To examine the role of MGL1 in KPn induced pneumonic sepsis, we first determined its 
transcript-level expression by real-time quantitative PCR using RNA from lungs of KPn-
infected wild-type (WT) mice. The results showed that MGL1 mRNA was maximally 
transcribed by 3dp.i. (Fig. 6A), a time when infiltration of immune cells is peaked during 
infection (66, 230).  To examine the expression of MGL1 at the protein level, in-situ IF 
microscopy was performed on lung cryosections of mock control and KPn infected WT 
mice at indicated post-infection times. In uninfected mock controls, the expression of 
MGL1 was at low basal level (Fig. 6B). Upon infection, this CLR was found to be 
abundantly expressed at 3dp.i., consistent with the high transcript level in lungs at that time 
(Fig. 6B). Interestingly, in addition to some infiltrating immune cells, MGL1 appeared to 
be expressed prominently by endothelial and alveolar epithelial cells in the lungs of these 
mice. This infection induced upregulation in the expression of MGL1 in pneumonic lungs 
during KPn infection indicated that this CLR likely plays a role in the pathogenesis of KPn 
pneumonia.  
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Figure 6. MGL1 is upregulated in the lungs of Klebsiella pneumoniae (KPn) infected 
pneumonic mice 
(A) Total RNA was extracted by Trizol method from the lungs of KPn infected wild-type 
(WT) C57/BL6 mice, harvested at indicated times post-infection. The mRNA levels of 
MGL1 were analyzed by real-time PCR as described in Methods and are expressed as fold 
changes over the levels in mock control mice calculated by using the formula 2−(ΔΔCt). Data 
shown are the mean ± SEM of 3-4 mice per time point in two independent experiments. 
Significant differences were measured by Student’s t test (p < 0.05) (B) MGL1 expression 
was examined by immunofluorescence staining on lung cryosections of mock control and 
KPn infected wild-type mice harvested at indicated times post-infection using an affinity 
purified anti-mouse MGL1 goat IgG followed by Alexa Fluor® 546 labelled (red) donkey 
anti-goat IgG. Nuclei (blue) were stained with 4′,6′-diamidino-2-phenylindole dilactate. 
Images shown are representative of 3 independent experiments with 3-4 mice each.  
 
Increased susceptibility of MGL1-/- mice to KPn pneumonia  
To examine the role of MGL1 in disease development, overall disease severity and survival 
was compared in wild-type (WT) and MGL1-/- mice infected with KPn. As the WT mice 
are also susceptible to KPn infection, in order to dissect the role of MGL1, we 
experimentally standardized a sublethal dose of KPn at which 60-70% of the WT mice 
resolve the infection and display only transient signs of disease (ruffled fur, lethargy) early 
during infection. We found that MGL1-/- mice were significantly more susceptible to this 
dose and majority of mice succumbed to infection by day 5p.i. (Fig. 7A). These mice 
exhibited progressive development of disease and overt signs of infection (weight loss, 
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piloerection, hunched gait, lethargy, increased respiratory rate). The increased 
susceptibility of MGL1-/- mice clearly indicated a protective role played by this CLR during 
pneumonic KPn infection. To examine the impact of MGL1 deficiency on the host 
antibacterial defense mechanism, comparison of local and systemic bacterial burden in the 
organs of infected WT and MGL1-/- mice was performed. Intriguingly, there were no 
statistically significant differences in the bacterial loads in lungs, liver or in blood of WT 
and MGL1-/- mice, although the MGL1-/- mice tended to exhibit higher burdens at later 
times post-infection (Fig. 7B). Based on this data, the protective function of MGL1 did not 
appear to correlate with reduced bacterial burden or systemic dissemination. 
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Figure 7. MGL1-/- mice exhibit reduced survival despite similar bacterial burden as 
the WT mice 
(A) WT and MGL1-/- mice were intranasally infected with 3.0x104 CFUs of KPn in 20µl 
of sterile PBS and were assessed daily for disease severity. The survival was monitored for 
two weeks. Statistical comparison of susceptibility was done by Kaplan-Meier survival 
curve statistical analysis (p=0.0019 **). The data shown is from 3 independent experiments 
(n=16). (B) WT and MGL1-/- were intranasally infected with KPn. At indicated times post 
infection the mice were sacrificed, systemic organs were isolated, homogenized and plated 
as described in Materials and Methods. Bacterial burden was enumerated after incubating 
the plates overnight at 37oC.  No significant differences in bacterial burden (using non-
parametric Mann-Whitney test) in WT and MGL1-/- were found. Each symbol in the scatter 
plots represents individual mouse and the data is from 3-4 independent experiments.  
 
Role of MGL1 in phagocyte function 
We next examined the direct effect of MGL1 deficiency on the bacterial uptake and killing 
capability of phagocytic cells i.e. neutrophils and macrophages.  As shown in Fig. 8A and 
B, WT and MGL1-/- neutrophils and macrophages were equally competent in phagocytosis 
and clearance of KPn. Studies from our and other laboratories have shown that KPn 
infection induces Neutrophil Extracellular Trap (NET) formation in-vivo in lungs of mice 
and that NETs can effectively inhibit the growth of KPn (66, 237). We thus compared the 
extent of NET formation in-vivo in the lungs of KPn infected WT and MGL1-/- mice. As 
shown in Fig. 8C, neutrophils isolated from BAL of infected MGL1-/- mice did not exhibit 
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any defect in extracellular trap formation. Together with our observation of similar 
bacterial burden in WT and MGL1-/- mice in-vivo, these data indicated that protective 
function of MGL1 was likely independent of the bacterial clearance mechanisms during 
pneumonic KPn infection. 
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Figure 8. MGL1 deficiency does not impair bacterial clearance by phagocytes 
Bacterial uptake and killing capacity of MGL1-/- and WT neutrophils (A) or bone-marrow 
derived macrophages (B) was determined at 1h and 3h by assessing intracellular CFUs in 
these cells as described in Methods. Data from a representative of 3 independent 
experiments is shown. (C) Neutrophils isolated from bronchoalveolar lavage fluid (BAL) 
of WT (upper panel) and MGL1-/- (lower panel) mice infected with KPn, were 
cytocentrifuged and stained with Sytox Green to visualize extracellular traps (NETs).   
Magnification 200X. Bar graph shows quantitation of NET forming neutrophils in BAL 
from KPn infected WT and MGL1-/- mice. Data are mean ± SEM from 8 mice per group 
in 3 independent experiments.  
 
MGL1-/- mice exhibit severe lung pathology and hyperinflammatory response 
We next compared the gross immunopathological changes and immune cell infiltration in 
KPn infected WT and MGL1-/- mice. The mock control mice of both strains displayed 
similar normal lung tissue morphology in H&E stained cryosections (Fig. 9a, 9e). A 
moderate transient infiltration of immune cells was observed in infected WT mice by day 
3p.i. which was reduced substantially by 5dp.i. (Fig. 9b-d). The overall architecture of the 
lungs was largely preserved in the WT animals throughout the course of infection. In 
MGL1-/- mice on the other hand, an increased immune cell infiltration was evident even at 
1dp.i. which progressively increased and resulted in pulmonary inflammation 
characterized by highly confluent immune cell infiltrates (Fig. 9f-h). To further examine 
the impact of MGL1 deficiency on inflammatory response, levels of multiple inflammatory 
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cytokines in lung homogenates were compared between KPn infected WT and MGL1-/- 
mice. While the mock controls displayed low basal levels of these cytokines, KPn infected 
WT mice exhibited increased amounts at 3dp.i., a time of peak bacterial burden and cellular 
infiltration (Fig. 9B).  Infected MGL1-/- mice on the other hand, exhibited significantly 
higher levels of inflammatory cytokines at that time compared to the WT mice (Fig. 9B). 
The levels of IL-10, an anti-inflammatory cytokine were also significantly higher in MGL1-
/- mice, suggesting a condition of “cytokine storm” typical of sepsis, where anti-
inflammatory host mediators are upregulated in an attempt to counter-balance the systemic 
inflammatory response (238-240). Together, our results show that MGL1 deficiency did 
not render the mice defective in their ability to mount an anti-inflammatory response to 
counter the on-going inflammation; instead these mice displayed a hyperinflammatory 
phenotype typically associated with sepsis. Our observations thus raised the possibility that 
despite a similar bacterial burden, increased lung pathology and hyperinflammatory 
response is causing increased susceptibility of MGL1-/- mice to KPn infection.  
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Figure 9. Pneumonic MGL1-/- mice exhibit severe lung pathology and 
hyperinflammatory response 
(A) Hematoxylin & Eosin staining of lung cryosections from mock control (a and e) and 
KPn infected WT (b,c,d) and MGL1-/- (f,g,h) mice isolated at indicated times post-
infection. Magnification 200X. (B) The lungs from mock control (WT-M and MGL1-/- M) 
and KPn infected WT and MGL1-/- (WT-Inf and MGL1-/- Inf) mice isolated at 3d p.i. were 
homogenized in PBS with protease inhibitors and analyzed commercially for host immune 
mediators by rodent multi-analyte profile (MyriadTM Rules-Based Medicine, Austin, TX). 
Results shown are mean ± SEM of 3-4 each infected and mock control mice from 2-3 
independent experiments. Statistical significance are denoted by asterisks (*, p<0.05; **, 
p<0.005). CRP; C-reactive protein. 
 
MGL1-/- mice display altered neutrophil accumulation and neutrophilic immune mediators  
Pneumonic infection with KPn typically results in immune cell infiltration in lungs. To 
examine if there were differences in the immune cell types infiltrating in the lungs of WT 
versus MGL1-/- mice, flow cytometry analysis of total lung cells was performed. The 
results revealed that the percent as well as absolute numbers of Ly6G+; Ly6C+ and 
CD11b+ myeloid cells were significantly higher in the infected MGL1-/- lungs than those 
in the WT mice (Fig. 10A and B).  We found no significant differences in the numbers of 
macrophages (F4/80+), dendritic cells (CD11c+), αβ T cells (TCRβ+) or B cells (CD19+). 
Further analysis of the data revealed that the percent as well as total numbers of 
Ly6G+CD11b+ neutrophils were increased 2-3 fold in the lungs of MGL1-/- mice upon 
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infection, as compared to the WT mice (Fig. 10C).   This indicated that MGL1 likely plays 
a role in regulating neutrophil infiltration and that increased susceptibility of these mice 
may be due to excessive neutrophil accumulation contributing to exacerbated lung 
pathology. This was further corroborated with the analysis of neutrophil associated 
immune mediators which revealed significantly higher levels of neutrophil 
chemoattractants (CXCL1, CXCL6), neutrophil survival mediator (GM-CSF) and 
neutrophil activation markers (MMP9, MPO) in lung homogenates of MGL1-/- mice, as 
compared to their WT counterparts (Fig. 11). Together our data suggested a neutrophilia-
promoting effect of MGL1 deficiency in KPn pneumosepsis, which results in severe 
pathology and hyperinflammatory response contributing to the increased susceptibility of 
MGL1-/- mice to KPn pneumonia. 
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Figure 10. Pneumonic MGL1/-/- mice exhibit increased neutrophil accumulation in 
their lungs 
(A) Flow cytometry analysis of total lung cells from mock and KPn infected WT and 
MGL1-/- at 3dp.i. Total lungs cells were isolated from mice by collagenase treatment 
followed by staining with antibodies against indicated cell markers as described in 
methods. Each bar represents percent cells positive for individual markers in lungs of 
indicated experimental mice. (B) Shows total number of cells positive for indicated cell 
markers.  Data shown are the mean ± SEM of 5-6 mice from 3-4 independent experiments. 
Statistical significance are denoted by asterisks (*, p<0.05). (C) Ly6G+CD11b+ 
neutrophils in lungs of KPn infected WT and MGL1-/- mice at 3dp.i. The cells were double-
stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as markers for 
neutrophils. The bar graph shows mean ± SEM of total number of neutrophils in lungs of 
3-4 mock control and 4-5 KPn infected WT and MGL1-/- mice each from 3 independent 
experiments. Contour plots shown on the right are from one representative experiment. 
Statistical significance are denoted by asterisks (*, p<0.05).  
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Figure 11. Pneumonic MGL1/-/- mice exhibit increased levels of neutrophil associated 
immune mediators  
The lungs from mock control and KPn infected WT and MGL1-/- mice were harvested at 
3dp.i. and analyzed commercially for host immune mediators by rodent multi-analyte 
profile (MyriadTM Rules-Based Medicine, Austin, TX). Levels of neutrophil 
chemoattractants and growth factor (CXCL1, CXCL6, GM-CSF) and activation markers 
(matrix metalloproteinase-9, MMP-9 and myeloperoxidase, MPO) are shown.  Results 
shown are mean ± SEM of 3-4 each infected and mock control mice from 2-3 independent 
experiments. Statistical significance are denoted by asterisks (*, p<0.05; **, p<0.005). 
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MGL-1 deficiency causes increased neutrophil influx into the lungs during KPn pneumonia 
In order to gain mechanistic insights into the role of MGL1 in neutrophil accumulation, we 
performed neutrophil adoptive transfer using WT and MGL1-/- neutrophils labelled with 
two different intracellular dyes. Injecting a mix of the two types of neutrophils and 
calculating the ratio of MGL1-/- neutrophils to WT neutrophils and vice versa, allowed us 
to assess the relative migration efficiency of WT and MGL1-/- neutrophils in the exact 
same microenvironment (Fig. 12A). Consistent with our pathological and flow cytometry 
findings, we observed that MGL1-/- neutrophils were recruited at a higher rate than their 
WT counterparts in pneumonic lungs of recipient WT as well as MGL1-/- mice (Fig.12B). 
Deficiency of MGL1 on endothelial and possibly other resident cells did not appear to 
affect neutrophil recruitment, as evidenced by similar migration of WT neutrophils in 
MGL1-/- and WT mice (Fig. 12B black bar).   These results further solidified the fact that 
MGL1-/- neutrophils exhibit an increased capacity to infiltrate the lungs during KPn 
pneumonia indicating a previously undetermined role of MGL1 in controlling neutrophilia 
during pneumonic infection.   
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Figure 12. MGL1 deficiency causes increased neutrophil influx in the pneumonic 
lungs  
(A) Schematic representation of the adoptive transfer experiment as described in the 
Methods. Purified bone marrow neutrophils from WT mice were labelled with CellTracker 
Orange CMTMR and those from MGL1-/- mice labeled with CellTracker Green CMFDA, 
mixed in 1:1 ratio and injected intravenously (i.v.) into WT or MGL1-/- recipient mice 
infected intranasally with KPn 24h prior to injection. Lungs were harvested 2 hrs after the 
adoptive transfer and processed for flow cytometry. (B) Relative recruitment of MGL1-/- 
and WT neutrophils in each mouse strain is depicted as the ratio of indicated populations 
in the KPn infected lungs. Data shown are mean ± SEM form 9 mice per group in 3 
independent experiments. Statistical significance are denoted by asterisks (**, p<0.005).  
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Discussion 
Gram-negative pneumonic sepsis remains a serious healthcare challenge despite effective 
antibiotic treatments. This underscores that erratic host response to the infectious insult is 
an important element in determining the outcome of the disease. Here we report that 
MGL1, a host CLR, impacts the outcome of Klebsiella induced pneumosepsis as evidenced 
by a reduced survival, severe neutrophilic lung pathology and hyperinflammation of 
MGL1-/- mice. While the antimicrobial functions of neutrophils and macrophages remain 
unaffected by MGL1 deficiency, the mechanistic basis for the observed differences 
between the WT and MGL1-/- mice appeared to be de-regulated neutrophil influx and 
excessive, non-resolving inflammation. Our study shows, for the first time, a protective 
role of MGL1 in Gram-negative pneumonic sepsis by controlling neutrophil influx into the 
lungs. 
CLRs, by way of their abundant expression on phagocytic cells, can mediate pathogen 
uptake and antigen presentation (241-243). MGL1 has been shown to mediate the 
attachment and entry of influenza A virus (244) and recombinant MGL1 can bind intestinal 
commensal bacteria (222). We examined if this CLR plays any role in KPn uptake and 
clearance by phagocytic cells which may explain the increased susceptibility of MGL1-/- 
mice to this infection. Strikingly, we observed no difference in the phagocytic and bacterial 
killing capacity of neutrophils and macrophages, two cells types involved in KPn 
phagocytosis and clearance. Neutrophils can also kill pathogens by the release of NETs 
composed of chromatin decorated with neutrophil derived proteins (245). The NETs have 
been demonstrated to play a role in controlling KPn growth (59, 66, 237). However, similar 
to the phagocytosis and intracellular killing, we did not find any defect in NETs formation 
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in MGL1-/- neutrophils in-vivo. Together, these observations correlated with similar local 
and systemic bacterial burden in WT and MGL-1-/- mice and led to the possibility that the 
poor disease outcome in the absence of MGL1 is due to its impact on host immune 
responses other than those directly affecting antibacterial mechanisms.   
Unlike humans, who express only one form of MGL, mice have two orthologues of this 
CLR: MGL1 and MGL2 (211). MGL1 and MGL2 have been suggested to perform non-
redundant functions with MGL1 being most widely studied for its role in inflammatory and 
infectious disease conditions (211). To the best of our knowledge, there are no reports to 
suggest that MGL2 expression is modulated due to a deficiency of MGL1 in MGL1-/- mice. 
While this will require detailed structural and functional studies utilizing MGL2-/- mice, 
our data presented in this manuscript shows a clear phenotype of increased susceptibility 
and poor disease outcome in the absence of MGL1 in MGL1-/- mice. Moreover, unlike 
MGL1, KPn infection did not cause any increase in expression of MGL2 at the transcript 
level in infected mouse lungs as compared to the uninfected control mice (data not shown). 
Whether or not MGL2 is involved synergistically, directly or indirectly; could be a topic 
of future investigation.  
Despite a similar bacterial burden, MGL1 deficiency resulted in more severe lung 
pathology and heightened inflammatory response. These mice displayed 
hyperinflammation and a lack of resolution in their lungs, suggesting a protective, pro-
resolving role of MGL1 in pneumosepsis. Both anti- as well as pro-inflammatory functions 
of MGL1 have been described in distinct pathological conditions. Increased susceptibility 
of MGL1-/- mice to helminth parasitic infection with Taenia crassiceps was shown to 
correlate with reduction in the levels of proinflammtory cytokines (246).  An MGL-
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dependent induction of pro-inflammatory cytokines, TNF-α, IL-6 and IFN-ɣ in Bordetella 
pertussis stimulated mast cells was reported (221), however, the relevance of these findings 
to overall disease outcome was not examined. In contrast to these studies, an anti-
inflammatory role of MGL1 was described in experimental colitis, where the protective 
function of MGL1 was attributed to induction of IL-10 by colonic lamina propria 
macrophages in response to commensal bacteria (222).  We observed an excessive 
upregulation of both pro- as well as anti-inflammatory cytokines in MGL1-/- mice 
undergoing KPn pneumoseptic infection. It is likely that the presence of multiple PAMPs 
and alarmins released due to bacterial growth and/or inflammation contributes to the effect 
of MGL1 deficiency and causes stimulation of multiple PRRs on immune cells resulting in 
a mixed pro-and anti-inflammatory hyper response reminiscent of characteristic cytokine 
storm. Indeed, a cross-talk between CLRs and Toll-like receptors (TLR)-induced immune 
responses has been reported where CLR mediated uptake of Schistosoma antigens 
suppresses TLR-mediated dendritic cell maturation (247). Whether an inverse relationship 
between MGL1 and TLR signaling exists or if MGL1 negatively regulates TLR stimulation 
in KPn pneumonia remains to be determined. Nonetheless, the fact that a 
hypeinflammation and more severe pathological changes were observed in MGL1-/- mice 
despite a similar bacterial burden indicate that MGL1 negatively regulates the 
inflammation and a perpetuation of inflammation rather than the bacterial growth 
contributes to lethality of MGL1-/- mice.  
We found that KPn infected MGL1-/- mice exhibited significantly increased neutrophil 
accumulation in their lungs.  Neutrophil mediated responses are essential for combating 
pneumonic bacterial infection and their protective role in sepsis and KPn infection in 
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particular has been described elegantly (248, 249). However, persistent accumulation of 
neutrophils can lead to bystander tissue destruction, owing to their tissue destructive cargo. 
Accumulation of large numbers of neutrophils in the lungs of MGL1-/- mice and higher 
amounts of their associated inflammatory mediators suggested that there is a defect in 
neutrophil turnover in these mice. This could either be due to increased influx of 
neutrophils into the lungs; due to a defect in their clearance by efferocytosis; or a 
combination of both. While we are currently investigating the role of MGL1 in 
efferocytosis, our adoptive transfer experiment showed that MGL1 deficiency on 
neutrophils significantly increases their capacity to infiltrate the lungs of pneumonic mice. 
This suggested a novel role of MGL1 as a negative regulator of neutrophil influx, although 
previous studies have implicated this CLR in trafficking of other myeloid cell types.  
Relevant to our study, mouse MGL has been reported to impede migration of immature 
dendritic cells (DCs) via its interaction with its glycan ligands on endothelium, and 
blockage of MGL results in an enhanced random mobility of these cells (250). Mature DCs 
lose MGL expression (251), thus enabling these cells to overcome the negative effect of 
MGL and egress. Similar mechanisms could be at play in our model where MGL1 
negatively regulates epithelium-neutrophil interactions thereby impeding neutrophil 
infiltration into the intrapulmonary space and retaining them into circulation, and only after 
MGL1 expression is lost, are these neutrophils able to infiltrate into the lungs. This could 
also explain why we could not detect MGL1 expression on neutrophils infiltrating the lungs 
of KPn infected WT mice (data not shown). Curiously, while MGL1 was expressed on 
bronchial epithelial and endothelial cells in lungs, we did not see a significant effect of 
endothelial cell expressed MGL1 on neutrophil influx (evidenced by similar infiltration of 
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labelled WT neutrophils in MGL1-/- and WT mice). While the role of MGL1 expressed on 
other resident cells cannot be ruled out at this time, the significance of this endothelial 
expression pattern remains to be experimentally determined.  
In the absence of MGL1 we also observed significantly higher induction of neutrophil 
chemoattractants (CXCL1 and CXCL6), neutrophil survival mediator (GM-CSF) and 
neutrophil activation markers (MMP9, MPO) in MGL1-/- mice, as compared to their WT 
counterparts. These results further support the notion that MGL1 is likely involved in 
neutrophil turnover and the absence of MGL1 results in greater and prolonged 
accumulation of neutrophils in lungs of mice. This leads to a greater neutrophil-mediated 
inflammation and lung pathology observed in MGL1-/- mice as compared to their WT 
counterparts where the neutrophils infiltrate transiently and are cleared off as the infection 
resolves. These observations clearly suggest that while deficiency of MGL1 does not 
impair bacterial phagocytosis and activation of neutrophils, this CLR is required for 
regulating neutrophil trafficking. 
In summary, this study shows that MGL1 plays an important role in mitigating the 
inflammation during a pneumonic infection, by negatively regulating the neutrophil influx. 
This study opens up new avenues of research on the role of MGL1 in neutrophil trafficking. 
This can have major implications in the therapeutic measurements of inflammation 
associated disorders. 
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Current Work 
I am currently working to understand the mechanistic underpinnings of massive neutrophil 
accumulation in the lungs of MGL1-/- mice. We hypothesized that the accumulation of 
neutrophils in the lungs of MGL1-/- mice could be due to either an increase in influx into 
the lungs or a defect in their ability to be cleared via efferocytosis; or a combination of 
both. I tested both possibilities and found that: 
MGL1 deficiency leads to an increase in neutrophil mobilizing factors during KPn induced 
pneumonia 
The adoptive transfer experiment described above indicated that MGL1 plays a role in 
negatively regulating neutrophil influx. In order to gain mechanistic insight into this, we 
analyzed the levels of neutrophil mobilizing factors Granulocyte Chemotactic Protein-2 
(GCP-2) and Granulocyte-Colony Stimulating Factor (G-CSF) levels in the lung 
homogenates of uninfected mock control and KPn infected WT and MGL1-/- mice at 3dp.i. 
The basal levels of these mediators in the lung homogenate of uninfected WT and MGL1-
/-  uninfected mice was similar. However, by 3dp.i. MGL1-/- mice had significantly elevated 
levels of both neutrophil mobilizing factors in their lungs compared to WT mice (Fig 13). 
Elevated G-CSF levels are known to cause emergency granulopoiesis (252-261) which is, 
a form of hematopoiesis for granulocytes and occurs constantly to maintain a steady state 
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of mature granulocytes in the blood. In the case of severe systemic infection a demand-
adapted granulopoietic response (emergency granulopoiesis) kicks in to drastically 
increase the number of neutrophils to meet the current situation (252). We next analyzed 
granulopoiesis in WT and MGL1-/- mice upon KPn infection. 
 
Figure 13. Pneumonic MGL1−/− mice exhibit increased neutrophil mobilizing factors 
in their lungs 
Lung homogenate from K. pneumoniae–infected WT and MGL1−/− mice at 3 d p.i. were 
analyzed for a number of chemokines, cytokines, and growth factors. Data represented 
above shows Granulocyte Chemotactic Protein-2 (GCP-2) and Granulocyte-Colony 
Stimulating Factor (G-CSF). (n = 3) *p < 0.05, **p < 0.005. 
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Pneumonic MGL1-/- mice display an increase in mature neutrophil mobilization from 
reserves in the bone marrow 
We analyzed the process of granulopoiesis in WT and MGL1-/- mice over a 3-day time 
course beginning at 6 hours post KPn infection via flow cytometry. Using the 
hematopoietic stem cell marker c-Kit, granulocyte marker Ly6G, and gating on different 
subpopulations; we quantitated the number of progenitor cells (c-Kit++ Ly6G-), early 
granulocytes (c-Kit_Low Ly6G_Low), and mature neutrophils (c-Kit- Ly6G+) in the bone 
marrow and blood of WT and MGL1-/- mice. As shown in Figure 14, there was no 
difference in the numbers of progenitor cells, early granulocytes, or mature neutrophils in 
bone marrow or blood of uninfected mock as well as at 6hr p.i. and 1dp.i. in WT and MGL1-
/- mice. However, by 3dp.i. MGL1-/- mice had increase numbers of progenitor cells, early 
granulocytes, and mature neutrophils in the blood compared to the infected WT mice. 
These results suggested that in the absence of MGL1, increase in neutrophil mobilizing 
factors in the lungs, there is increased mobilization of mature neutrophils from the bone 
marrow. 
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Figure 14. Pneumonic MGL1-/- mice showed an increased mobilization of neutrophil 
reserves from bone marrow 
WT and MGL1-/- mice were infected with K. pneumoniae and the generation and 
mobilization of hematopoietic progenitor cells to mature neutrophils via the process of 
granulopoiesis was checked at the indicated time points in the blood and bone marrow. (n 
= 6). Data was analyzed as shown above, using cKit to identify hematopoietic stem cells 
and Ly6G to identify neutrophils. cKit+ Ly6G- cells are progenitors, cKit_Low 
Ly6G_Low cells are early granulocytes, and CD11b+ Ly6G+ cells are mature 
neutrophils. *p < 0.05, **p < 0.005. 
 
Absence of MGL1 on neutrophils negatively impacts the uptake of neutrophils by alveolar 
macrophages 
Previous reports have shown that the efferocytosis of apoptotic neutrophils is able to 
regulates granulopoiesis by reducing the production of granulopoietic stimulating factors 
such as G-CSF (262). To examine this we performed an in-vivo efferocytosis experiment 
by administering CFSE labelled WT or MGL1-/- neutrophils intranasally into WT mice 
followed by isolation of alveolar macrophages by lung lavage. The macrophages were then 
analyzed by flow cytometry to quantitate Ly6G-F4/80+CFSE+ efferocytic cells. As shown 
in Figure 15, MGL1-/- neutrophils were efferocytosed less than WT neutrophils by WT 
alveolar macrophages, indicating a defect in the clearance of neutrophils in the absence of 
MGL1 expression on their surface. 
68 
 
 
Figure 15. MGL1-/- neutrophils are efferocytosed less by alveolar macrophages in-
vivo compared to WT neutrophils 
CFSE labelled WT or MGL1-/- neutrophils were instilled intranasally in anaesthetized mice 
(3.5 million cells in 35 µl PBS). Two hours later lungs were lavaged as described in 
methods and cells were stained with PE-Cy7 conjugated anti-F4/80 and APC conjugated 
anti-Ly6G antibodies for flow cytometry.  
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Figure 15 cont. MGL1-/- neutrophils are efferocytosed less by alveolar macrophages 
in-vivo compared to WT neutrophils 
Percentage of efferocytic uptake by macrophages was quantitated by enumeration of 
Ly6G- F4/80+ CFSE+ cells. Data are from 4 mice per group in 2 independent experiments 
(**, p<0.005). 
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Abstract 
Background: Nosocomial infections with Klebsiella pneumoniae (KPn) are a frequent 
cause of Gram-negative sepsis. To understand the functioning of host innate immune 
components in this disorder, we examined a previously uninvestigated role of C-type lectin 
receptor Mincle, in pneumonic sepsis caused by KPn.  
Methods: Disease progression in wild-type and Mincle-/- mice undergoing pulmonary 
infection with KPn was compared.   
Results: While the wild-type mice infected with a sublethal dose of bacteria could resolve 
the infection with bacterial clearance and regulated host response, the Mincle-/- mice were 
highly susceptible with a progressive increase in bacterial burden despite their ability to 
mount an inflammatory response which turned to an exaggerated hyperinflammation with 
the onset of severe pneumonia. This correlated with severe lung pathology with a massive 
accumulation of neutrophils in their lungs.  Importantly, Mincle-/- neutrophils displayed a 
defective ability to phagocytize non-opsonic bacteria and an impaired ability to form 
extracellular traps (NETs), an important neutrophil function against invading pathogens, 
including KPn.  
Conclusion: Our results demonstrate protective role of Mincle in host defense against KPn 
pneumonia by coordinating bacterial clearance mechanisms of neutrophils. A novel role 
for Mincle in regulation of NETosis may have implications in chronic disease conditions 
characterized by deregulated NET formation. 
 
Key words: Mincle, Clec4e, Klebsiella, pneumonia, sepsis, neutrophils, NETs, 
phagocytosis  
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Introduction 
Lower respiratory tract infection with bacteria can lead to sepsis development, which is a 
complex immune disorder characterized by a systemic hyperinflammation. There are 
currently no effective therapies for sepsis that results in 750,000 hospitalizations annually 
in the United States with a mortality rate of 20-50% (2, 224). Nosocomial infections with 
opportunistic pathogen Klebsiella pneumoniae (KPn) account for 5-20% of Gram-negative 
sepsis cases (223, 225, 263). Additionally, emergence of multidrug resistant isolates of 
KPn in clinical settings is a serious health concern. As innate mucosal immunity plays a 
direct role in bacterial killing and immunomodulation in this acute infection (237, 248, 
264-266), an understanding of functioning of host innate immune components might 
provide targets for modulation of host immune system in a beneficial manner. 
Mincle is a C-type lectin receptor (CLR) belonging to the Dectin-2 subfamily of innate 
immune receptors that can function as an activating receptor for host- as well as pathogen-
associated molecular patterns, termed alarmins and PAMPs respectively (reviewed in (213, 
214). It is an inducible receptor, expressed mainly by myeloid cells such as macrophages, 
neutrophils, myeloid dendritic cells as well as some B-cell subsets (213, 215, 267).  
Functional analysis of this receptor in macrophages has received the most attention, where 
its association with FcRγ activates downstream signaling cascades involving Syk kinases 
resulting in induction of protective inflammatory response (84, 109, 268). While the 
function of Mincle in chronic bacterial infections such as tuberculosis and fungal infections 
was examined in these studies, its role in acute pneumonic infections leading to sepsis 
development has not been explored. Furthermore, its functions other than as an 
inflammatory PRR (Pattern Recognition Receptor) have received little, if any, attention.   
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Neutrophil mediated responses are essential for combating pneumonic bacterial infection 
and their protective role in sepsis and KPn infection in particular has been described (249, 
269). The professional antimicrobial program of neutrophils mainly constitutes 
phagocytosis of infectious agents followed by production of noxious agents such as 
reactive oxygen species which kill the internalized microbes. Another recently established 
mechanism of microbial killing by neutrophils is by formation of extracellular traps 
(termed neutrophil extracellular traps or NETs) which are DNA fibrils expelled by these 
cells that are decorated with granular contents such as various proteases and can ensnare 
and kill the microbes without phagocytosis (59, 270, 271). Mincle has been shown to be 
expressed by neutrophils and while shown to play a role in neutrophil mediated protective 
responses against Candida and mycobacteria (105, 107), its direct role in bacterial 
phagocytosis and NET formation is not known. Since neutrophils are a key cell type in 
controlling KPn infection, Mincle signaling in neutrophils may be a key event in control 
of KPn infection and sepsis. 
In this study, we examined the role of Mincle in acute KPn infection causing pneumonic 
sepsis. Our results suggest novel protective function of Mincle as non-opsonic phagocytic 
receptor for the bacteria and in regulation of neutrophil NET formation indicating the 
importance of this CLR in neutrophil-specific bacterial clearance mechanisms in 
pneumonic infections.  
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Materials and Methods 
Bacterial strains and Mice 
The KPn (ATCC strain 43826) were grown to log phase in LB medium at 37oC. All in-
vivo experiments were performed using 6-8 weeks old female wild-type C57BL/6 or 
Mincle-/- mice on same background obtained from the Consortium of Functional Genomics, 
Scripps, La Jolla and bred in the animal facility of the University of North Dakota. The 
animals were used according to institutional and federal guidelines.  
Infection of Mice, survival and bacterial burden   
Mice were anaesthetized with a mixture of 30mg/ml ketamine and 4 mg/ml xylazine in 
PBS and were infected intranasally with sublethal dose (2.5 x 104 bacteria in 20ul of saline, 
determined experimentally) of KPn or with 20 µl of saline alone. Survival of the mice was 
recorded for up to 2 weeks post-infection (p.i.). In some experiments, the mice were 
euthanized at indicated times p.i. and blood, lungs and liver were aseptically homogenized 
in cold PBS with CompleteTM protease inhibitor cocktail (Roche Diagnostics, Germany). 
For the bacterial burden analyses, serially diluted homogenates and blood were plated on 
LB agar and incubated at 37oC overnight.  
Quantitative real-time PCR 
Total RNA from lungs of infected and mock control mice harvested at various times p.i. 
was extracted using Trizol reagent (Invitrogen) according to the manufacturers' 
instructions. Real-time PCR analysis was performed using SYBR green (Applied 
Biosystems, CA, USA) to measure the expression levels of Mincle-specific mRNA by 
using specific primers (sense) 5'- ACC AAA TCG CCT GCA TCC -3' and (anti-sense) 5'- 
CAC TTG GGA GTT TTT GAA GCA TC -3' (as described by us in (89).  The target gene 
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expression levels were normalized to levels of the house keeping 18S gene in the same 
sample. Expression of Mincle in infected samples was determined as fold change over that 
in control samples as calculated by using the formula 2−(ΔΔCt). 
Multi-analyte profile analysis 
The lung homogenates were prepared as described for the bacterial burden analysis above 
and were centrifuged at 2000 x g for 15 min to clear cellular debris. The supernatants were 
immediately frozen at -80o C. The biomarker levels in lung homogenates were determined 
commercially by Myriad Rules-based Medicine (Austin, TX, USA) utilizing a multiplexed 
analysis. 
Histological analysis 
For histological analysis, frozen lung tissues were processed as previously described (227, 
228). Serial horizontal sections (10 µm thick) of frozen lung tissues thus obtained were 
stained with hematoxylin and eosin for pathological analysis as previously described (229, 
230) .  
Flow Cytometry  
Lungs or BAL cells were harvested from mice at 3 days p.i. and processed as previously 
described by us (227, 228, 231). Enumeration of neutrophils by flow cytometry (using a 
BD LSR II, Becton Dickinson, San Jose, CA) was done by quantitating Ly6G+CD11b+ 
cells stained with Pacific BlueTM anti-mouse CD11b and APC anti-mouse Ly6G (Clone 
1A8) antibodies (Biolegend, San Diego, CA). Mincle expression was examined by using a 
rat anti-mouse Mincle monoclonal antibody (Clone 6G5, InvivoGen, CA) followed by goat 
anti-rat Alexa-488 secondary antibody (InvitroGen, OR). FlowJo (Tree Star) software was 
used to analyze all data.  
76 
 
 
Bacterial phagocytosis by neutrophils 
Bacterial phagocytosis of WT and Mincle-/- neutrophils was assessed by flow cytometry. 
For this, peritoneal neutrophils were isolated using an established model of thioglycollate-
induced peritonitis. Sterile 4% thioglycollate was injected in peritoneal cavity of mice and 
neutrophils enriched 8-12h following the injection were isolated (95-99% pure as assessed 
by flow cytometry using GR1 and CD11b antibodies). Neutrophils were incubated with 
GFP-labeled KPn (kindly provided by Dr. Steven Clegg, University of Iowa) for 1 hour 
and washed three times with ice-cold FACS-buffer (PBS+10% fetal bovine serum). 
Fluorescence of the attached but non-internalized bacteria was quenched by treating the 
cells with 0.04% Trypan Blue. The % positive cells containing fluorescent bacteria were 
determined by flow-cytometry using uninfected neutrophils as control.  
Neutrophil NETs 
For detection of neutrophil NETs in-vivo, the bronchoalveolar lavage (BAL) was 
performed in WT and Mincle-/- mice at 3dp.i.. The lavage cells were cytocentrifuged on 
glass slides and were co-stained with Sytox Green (Molecular Probe, Eugene, OR) and 
rabbit anti-neutrophil elastase (NE) polyclonal antibody (Abcam) followed by goat anti-
rabbit Alexa546 antibody. The percent NET formation was quantitated by dividing the 
number of NET-forming neutrophils by total number of cells in 8-10 random microscopic 
fields and multiplying the values by 100.  
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Statistical Analysis 
Statistical analysis of survival studies was performed by Kaplan Meir log-rank test; 
bacterial burdens by non-parametric Mann-Whitney Test. All other statistical analyses 
were performed using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose, 
CA). 
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RESULTS 
Mincle is highly expressed in lungs during pneumonic KPn infection.  
To examine the role of innate immune receptors in pathogenesis of KPn induced 
pneumonic sepsis, we initially screened a panel of 52 membrane-bound and soluble CLRs 
by Taqman Low-density arrays which showed an upregulated expression of Dectin-2 
family CLR, Clec4e (also called Mincle), among others in the lungs of mice undergoing 
respiratory KPn infection. To further confirm the Mincle expression, real-time quantitative 
PCR was performed using RNA from lungs of KPn infected wild-type mice. The results 
showed a progressive increase in the transcript level of Mincle mRNA which was 
maximally transcribed by 3dp.i. and remained at high level throughout the course of 
infection (Figure 16A).  Flow cytometry analysis further confirmed the increased numbers 
of Mincle-positive cells, majority of which were CD11b+Ly6G+ neutrophils, in the lungs 
of KPN-infected mice (Figure 16B). This indicated that Mincle was highly expressed on 
neutrophils and played a role in pathogenesis of KPn pneumonia.  
Mincle deficient mice are highly susceptible to KPn pneumonia.  
To examine the role of Mincle in disease development, overall disease severity and survival 
was compared in wild-type and Mincle-/- mice infected with a sub-lethal dose of KPn. This 
dose was experimentally determined at which the WT mice displayed minimal morbidity 
and mortality (230). As shown in Figure 16C, 76% of WT mice infected with 2.5x104 CFUs 
of KPn survived the infection with transient signs of disease (ruffled fur, lethargy) early 
during infection and appeared healthy later. The Mincle-/- mice, in contrast, were extremely 
susceptible to this dose and all mice succumbed to infection by day 6p.i. While majority of 
the infected WT mice cleared the infection by day 5 p.i., Mincle-/- mice exhibited 
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progressive development of disease and overt signs of infection (weight loss, piloerection, 
hunched gait, lethargy, increased respiratory rate). The increased susceptibility of Mincle-
/- mice clearly indicated a protective role played by this CLR during pneumonic KPn 
infection. 
 
Figure 16. Mincle is highly induced in the lungs of KPn infected pneumonic mice and 
Mincle deficiency increases susceptibility to the infection 
A. Total RNA was extracted by Trizol method from the lungs of KPn infected wild-type 
C57/BL6 mice, harvested at indicated time post-infection. The mRNA levels of Mincle 
were analyzed by real-time PCR as described in Methods and are expressed as fold changes 
over the levels in mock control mice calculated by using the formula 2−(ΔΔCt). Data shown 
are the averages of 6-8 mice per group in two independent experiments.  
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Figure 16 cont. Mincle is highly induced in the lungs of KPn infected pneumonic mice 
and Mincle deficiency increases susceptibility to the infection 
B. Mincle expression was examined on infiltrating lung cells from KPn infected wild-type 
C57/BL6 mice harvested at 3dp.i. by flow cytometry using a rat anti-mouse Mincle 
antibody followed by goat anti-rat secondary antibody labeled with Alexa-488. Mincle 
positive cells were gated and further analyzed for expression of CD11b and Ly6G as 
mentioned in the Methods section. The dot plots shown are representative of 3 independent 
experiments with 3 mice each. C. Fifteen each WT and Mincle-/- mice were intranasally 
infected with 2.5X104 CFUs of Klebsiella pneumonia (KPn) in 20µl of sterile PBS and 
were assessed daily for disease severity. The survival was monitored for two week. 
Statistical comparison of susceptibility was done by Kaplan-Meier survival curve statistical 
analysis (p<0.001).  
 
Mincle deficiency results in increased bacterial burden and systemic dissemination  
In order to examine if increased susceptibility of Mincle-/- mice to KPn infection correlated 
with inefficiency to clear bacteria, homogenized lungs, liver and blood from infected 
Mincle-/- and WT mice collected at various times post infection were plated on LB agar. 
Up to 2dp.i., Mincle-/- and WT animals displayed similar bacterial burdens in their lungs 
(Figure 17A). By 3dp.i., however, lungs of Mincle-/- mice exhibited significantly higher 
bacterial counts as compared to their WT counterparts. The bacterial burden in these mice 
remained high at 5dp.i., the time when majority of mice had become moribund. In contrast, 
the WT mice displayed 3-5 logs lower bacterial burden at 3dp.i. and the counts continued 
to drop through 5dp.i., indicating clearance of bacteria and resolution of the infection in 
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these mice. The Mincle-/-  mice also displayed a higher systemic dissemination of bacteria 
as depicted by significantly higher bacterial load in liver (Figure 17B) and a more severe 
bacteremia (Figure 17C). In contrast, no viable bacteria were detected in the blood of WT 
mice by 5dp.i. These data indicated that Mincle mediated responses directly or indirectly 
influenced bacterial clearance in pneumonic infection with KPn.  
 
82 
 
Figure 17. Mincle-/- mice display increased bacterial burden and systemic 
dissemination during pneumonic KPn infection  
WT and Mincle-/- were intranasally infected with 2.5X104 CFUs of KPn. At indicated times 
post infection the mice were sacrificed, systemic organs were isolated, homogenized and 
plated as described in Materials and Methods. Bacterial burden was enumerated after 
incubating the plates overnight at 37oC.  The data shown is from three independent 
experiments with 3-5 mice at each time point per experiment. Significant differences in 
bacterial burden (using non-parametric Mann-Whitney test) in WT and Mincle-/- are 
denoted by asterisks (*, p<0.05; **, p<0.005, ***p<0.001).  
 
Mincle-/- mice exhibit hyperinflammatory response 
We next examined if the inability of Mincle-/- mice to clear the bacteria was due to a defect 
in mounting inflammatory response. In both WT and Mincle-/- strains, mock infected 
mouse lungs displayed similar low basal levels of inflammatory cytokines tested (Figure 
18). Upon KPn infection, WT mice exhibited increased levels of these cytokines at 1dp.i., 
which started to drop by 3dp.i. and were reduced to minimal levels by 5dp.i. (Figure 18). 
This was consistent with the reduced bacterial burden in these mice at these times p.i..  In 
contrast, infection of Mincle-/- mice resulted in a progressive increase in levels of these 
cytokines through the course of infection, which remained high till the mice became 
moribund.  These mice in fact exhibited an overwhelming inflammatory response at 3d and 
5dp.i. (Figure 18). The levels of inflammatory cytokines and chemokines tested in lungs of 
these mice were significantly higher than WT mice at these time points. The levels of IL-
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10, an anti-inflammatory cytokine were also significantly higher in Mincle-/- mice, 
suggesting a condition of “cytokine storm” typical of sepsis, where anti-inflammatory host 
mediators are upregulated in an attempt to counter-balance the systemic inflammatory 
response (238-240). These results show that Mincle deficiency did not render the mice 
defective in their ability to mount an inflammatory response but these mice rather displayed 
a hyperinflammatory phenotype typically associated with sepsis. Our observations thus 
raised the possibility that Mincle likely plays a direct role in bacterial clearance and the 
hyperinflammation resulted due to activation of other PRRs and inflammatory receptors in 
response to persistent overwhelming bacterial burden in Mincle-/- mice undergoing 
pneumonic KPn infection.  
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Figure 18. Pneumonic Mincle-/- mice exhibit hyperinflammatory response  
The lungs from mock control and KPn infected WT and Mincle-/- mice were harvested at 
indicated time points post-infection, homogenized in PBS with protease inhibitors and 
analyzed commercially for host immune mediators by rodent multi-analyte profile 
(MyriadTM Rules-Based Medicine, Austin, TX). Results shown are average of 3-4 each 
infected and mock control mice from 3 independent experiments. Amounts of mediators 
shown were significantly higher (***p<0.001) in KPn infected Mincle-/- mice at 3dp.i. and 
5dp.i. in comparison with their levels in the infected WT mice at those time points tested. 
 
Effect of Mincle deficiency on neutrophil infiltration and overall lung pathology 
Since neutrophils are a key cell type involved in bacterial clearance and initiation of 
protective immune response during KPn pneumonia, we next compared neutrophil 
infiltration and gross immunopathological changes in KPn infected WT and Mincle-/- mice. 
The mock control mice of both strains displayed similar normal lung tissue morphology in 
H&E stained sections (Figure 19). A moderate transient infiltration of immune cells was 
observed in infected WT mice by day 3p.i. which was reduced substantially by 5dp.i. The 
overall architecture of the lungs was largely preserved in the WT animals throughout the 
infection. The Mincle-/- mice, on the other hand, displayed a progressive increase in 
immune cell infiltration, which were mainly neutrophils, based on characteristic multi-
lobed nuclei (Figure 19 inset). By day 3 p.i. substantially increased influx of cells was 
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observed in large lesions and by 5 p.i., extensive foci of consolidation were visible with 
massive accumulation of neutrophils around alveolar spaces (Figure 19). 
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Figure 19. Pneumonic Mincle-/- mice exhibit severe lung pathology characterized by 
massive neutrophil accumulation   
Hematoxylin & Eosin staining of lung cryosections from mock control and KPn infected 
WT and Mincle-/- mice isolated at indicated times post-infection. Magnification 100X. 
Inset shows a highly magnified area (1000X) of a lesion in infected Mincle-/- lung depicting 
neutrophils as indicated by characteristic multilobed nuclear morphology.  
 
Flow cytometry analysis of infiltrating cells in lungs confirmed that the majority of these 
cells were Ly6G+CD11b+ neutrophils (Figure 20A). The numbers of these cells were 
significantly higher in the infected Mincle-/- lungs than those in the WT mice (Fig. 20A, 
bar graph).  This correlated with significantly higher levels of neutrophil chemoattractants 
(CXCL1, CXCL6), neutrophil survival mediator (GM-CSF) and neutrophil activation 
markers (MMP9, MPO) in these mice, as compared to their WT counterparts (Figure 20B).  
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Figure 20. Increased neutrophil accumulation coincides with elevated expression of 
neutrophil chemoattractant and activation markers in lungs of KPn infected Mincle-
/- mice    A. Flow cytometry analysis of Ly6G+CD11b+ neutrophils in mock control (WT-
M and Mincle-/--M) and KPn infected (WT-Inf and Mincle-/--Inf) WT and Mincle-/- mice. 
Total lungs cells were isolated from mice by collagenase treatment at 3dp.i.. The cells were 
stained with anti-Ly6G-APC and anti-CD11b-Pacific Blue antibodies as markers for 
neutrophils. The bar graph shows average of total number of neutrophils in lungs of 2-3 
mock control and 3-4 KPn infected WT and Mincle-/- mice each from 3 independent 
experiments. Dot plots shown on the right are from one representative experiment. 
Statistical significance are denoted by asterisks (***, p<0.001). B. The lungs from mock 
control and KPn infected WT and Mincle-/- mice were harvested at indicated time points 
post-infection and analyzed commercially for host immune mediators by rodent multi-
analyte profile (MyriadTM Rules-Based Medicine, Austin, TX). Levels of neutrophil 
chemoattractants (CXCL2, CXCL6, GM-CSF) and activation markers (matrix 
metalloproteinase 9, MMP-9 and myeloperoxidase, MPO) shown are average of 3-4 each 
infected and mock control mice from 3 independent experiments. Amounts of mediators 
shown were significantly higher (***p<0.001) in Mincle-/- mice at 3dp.i. and 5dp.i. in 
comparison with their levels in the WT mice at those time points tested.   
 
Mincle-/- neutrophils are defective in KPn phagocytosis 
We next examined the bacterial uptake by Mincle-/- neutrophils, in light of an increased 
bacterial burden in Mincle-/- mice. For this, phagocytosis of GFP-labeled KPn was 
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compared between WT and Mincle-/- neutrophils by flow cytometry. As shown in Figure 
21, Mincle deficiency resulted in significantly reduced phagocytosis of non-opsonized 
bacteria by neutrophils. The uptake of opsonized bacteria was also reduced in Mincle-/- 
neutrophils as compared to the Mincle-sufficient WT cells, however the differences were 
not statistically significant. These results indicate that Mincle is likely a novel non-opsonic 
phagocytic receptor for KPn and plays an important role in bacterial uptake by neutrophils.  
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Figure 21. Mincle deficiency impairs neutrophil phagocytosis of non-opsonized 
bacteria Peritoneal neutrophils from WT and Mincle-/- mice were incubated with GFP 
(Green Fluorescent Protein)-labeled KPn with (opsonized) or without (non-opsonized) 
10% normal mouse serum for 1 hour followed by quantitation of phagocytosis by flow 
cytometry. The results are expressed as % cells positive for fluorescent bacteria.  
Significant differences are denoted by asterisks (**, p<0.005).  
 
Mincle-/- neutrophils are defective in NET formation 
Extracellular trap formation is an important mechanism by which neutrophils clear 
extracellular bacteria. Since Neutrophil NET mediated killing has been shown to play a 
role in KPn clearance (237, 272), we saught to determine if Mincle deficiency resulted in 
a defect in NET formation. In order to minimize the tissue processing to avoid degradation 
of NETs, neutrophils isolated from BAL were used. Flow cytometry analysis showed that 
neutrophils were a predominant cell-type in the BAL of infected WT and Mincle-/- mice 
(Figure 22A). A quantitative comparison of BAL neutrophils showed that significantly 
higher numbers Mincle sufficient WT neutrophils produced NETs (Figure 22B) which 
stained positive for neutrophil-specific enzyme neutrophil elastase (Figure 22C), showing 
that these fibrillar structures originated mainly from neutrophils. Furthermore, the NETs 
observed in Mincle-/- neutrophils appeared dwarfed and lacked the web-like appearance as 
observed in the WT mice. This observation, together with reduced phagocytic ability of 
Mincle-/- neutrophils shows that Mincle deficiency severely impairs neutrophil mediated 
bacterial uptake and clearance mechanisms in lungs during pneumonic KPn infection.     
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Figure 22. Mincle deficiency causes a defect in formation of neutrophil extracellular 
traps (NETs) in the lungs of mice upon pneumonic KPn infection 
A. Enumeration of CD11b+Ly6G+ neutrophils by flow cytometry in BAL isolated from 
KPn infected WT and Mincle-/- mice. B. Quantitation of neutrophils showing NETs in BAL 
isolated from WT and Mincle-/- mice infected with KPn. (***p<0.001). C. Representative 
fluorescence images of the neutrophils isolated from BAL fluid of WT (upper panel) and 
Mincle-/- (lower panel) mice infected with KPn, and stained with Sytox Green to label DNA 
(green) and a rabbit anti-neutrophil elastase (NE) polyclonal antibody followed by goat 
anti-rabbit Alexa546 (red). The neutrophils from WT mice showed web-like structures that 
stained positive for NE and Sytox green (white arrow), while the Mincle-/- neutrophils 
appeared inactive and displayed occasional small DNA fibers that lacked the typical web-
like appearance of NETs (blue arrow). The experiment was repeated 3 times with 3-4 mice 
in each group. Magnification 400X.        
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DISCUSSION 
Pneumonic sepsis is a major health care burden worldwide and K. pneumoniae (KPn) is 
the most frequent Gram-negative sepsis-associated opportunistic pathogen (224). An 
imbalance of innate immune responses resulting in deleterious and prolonged inflammation 
and impairment of protective functions of first responder cells such as neutrophils have 
been directly correlated with sepsis-associated mortality (23, 273, 274). This warrants an 
improved understanding of functioning of innate immune components in this deadly 
disease. In this study, we sought to determine the role of Mincle, an innate immune C-type 
lectin receptor in KPn pneumonia. Here we report several novel findings: 1) We show, for 
the first time, a clear phenotype in terms of a severely reduced survival rate of Mincle-/- 
mice upon pneumonic KPn infection; 2) the reduced survival is not due to a defect in ability 
to mount an inflammatory response in absence of Mincle; 3) Mincle acts as a non-opsonic 
phagocytic receptor mediating uptake of KPn by neutrophils; and 4) Mincle deficiency 
results in a defect in neutrophil NET formation upon KPn infection.  Our results thus show 
that Mincle is required for defense against KPn induced pneumonic sepsis and that lack of 
Mincle causes a defect in neutrophil mediated bacterial clearance mechanisms such as 
phagocytosis and NET formation.  
Mincle has been previously shown to play a role in eliciting inflammatory responses 
against Mycobacterium, Candida albicans and skin fungal pathogens, Malassezia and 
Fonsecaea (104, 108, 109, 275). In these infections, Mincle expressed on macrophages, 
upon recognition of its ligands triggers FcRγ-Syk-Card9 pathway to induce production of 
protective Th1/Th17 responses as well as chemokines required for recruitment of 
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inflammatory cell types (85, 268, 275).  The increased susceptibility to these infections in 
the absence of Mincle was measured in terms of increased bacterial and fungal burden 
which was attributed to reduced inflammatory response and defective pathogen clearance 
in these studies. However, overall survival of the experimental animals was not affected 
by Mincle deficiency. Our study for the first time, reports a clear outcome where Mincle 
seems to play a non-redundant role in survival of KPn infected pneumonic mice. Moreover, 
the reduced survival of Mincle-/- mice is not due to their inability to mount an inflammatory 
response. These mice, instead exhibit hyperinflammation in their lungs suggesting that the 
protective ability of Mincle was independent of its role in eliciting inflammatory response. 
It is likely that the redundant function of other PRRs, upon recognition of bacterial PAMPs 
and endogenous alarmins generated from increased bacterial growth and accumulation of 
dead cells over time, is sufficient to induce inflammation in the absence of Mincle. Indeed, 
Mincle-/- mice in our studies, exhibited overwhelming local as well as systemic bacterial 
burdens.  
Concomitant to increased bacterial burden, Mincle-/- mice exhibited extensive neutrophil 
accumulation, the primary cell type shown to play an important role in mediating protective 
immune response against Kpn infection (248, 263, 269, 276). We thus examined if Mincle-
/- neutrophils were defective in performing cellular functions such as internalization of 
bacteria via phagocytosis which would explain increased bacterial burden in Mincle-/- mice 
despite a heightened inflammation. Indeed, Mincle-/- neutrophils showed a mitigated 
phagocytosis of non-opsonized, but not opsonized KPn, suggesting a non-redundant and 
direct role of Mincle for internalization of non-opsonized bacteria. To the best of our 
knowledge, this is the first study reporting Mincle as a non-opsonic phagocytic receptor. 
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Ongoing studies in our lab are currently investigating Mincle specific ligand of KPn, nature 
of this interaction and production of specific antibodies that can inhibit this interaction.   
Lectinophagocytosis or lectin-mediated uptake by macrophages has been reported 
previously for several pathogens (reviewed in (148). However, the receptors or 
mechanisms of non-opsonized phagocytosis of bacteria by neutrophils are poorly 
understood. Non-opsonic phagocytosis by receptors like Mincle may be important during 
early stages of infection before the onset of humoral immunity to generate opsonins, and 
in complement deficient or immunosuppressed patients. This mode of phagocytosis is 
particularly significant for inhaled bacteria as serum and complement components are as 
such limited in the alveolar space (277). Although appearance of serum components in 
alveolar space is common during severe KPn pneumonia, owing to high binding capacity 
of Mincle to mannose and N-acetyleglucosamine (278), uptake by Mincle of KPn with 
mannan-rich capsule in lungs could be a major mechanism of bacterial clearance in lungs.  
Absence of Mincle and a resulting defect in initial phagocytic uptake of KPn, as observed 
in our studies likely contributes to the increased bacterial burden and subsequent 
inflammation via activation of other PRRs such as TLRs.  
One of the more recently defined mechanisms of antimicrobial activity of neutrophils is 
extrusion of fibrous mesh of chromatin that entraps extracellular pathogens (59). These 
structures, termed NETs, are decorated with antimicrobial factors normally contained 
within neutrophil granules and represent an important strategy of neutrophils to immobilize 
and kill pathogens. Our observation reported in this study that Mincle-/- neutrophils are 
defective in NET formation in-vivo during KPn infection coincides with overwhelming 
bacterial burdens in these mice. These results are in line with previous reports indicating 
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that NET mediated killing is an important mechanism of bacterial clearance and protection 
against KPn induced pneumonia (237, 272). How Mincle regulates NET formation is 
currently under investigation in our laboratory and is expected to provide novel insights 
into mechanism of NETosis. This will have important implications in chronic disease 
conditions where deregulated NET formation is associated with the pathophysiology.   
Taken together, our results show that Mincle plays a protective role in KPn induced 
pneumonic sepsis by regulating neutrophil phagocytosis and NET formation, two 
important mechanisms of antimicrobial activity of neutrophils. Particularly, the novel 
observation of Mincle as a potential new component of NETosis pathway implicates this 
CLR in a much wider range of biological functions that initially surmised.  
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Abstract 
A profound neutrophilia and neutrophilic inflammation is characteristic of pneumoseptic 
infections with bacterial pathogens including Klebsiella pneumoniae (KPn). In homeostatic 
conditions, macrophages clear neutrophils by efferocytosis, via recognition of “eat me” 
signal phosphatidylserine (PS) exposed exofacially on these cells. We demonstrate here 
that infection with live, but not heat-killed KPn inhibits the efferocytic uptake of 
neutrophils in-vitro and in-vivo by macrophages. This infection-induced inhibition of 
efferocytosis correlated with a drastic decrease in surface exposed PS as well as induction 
of nonapoptotic cell death by necroptosis in KPn infected neutrophils. Concomitantly, 
treatment with sulfhydryl agent N-ethylmaleimide (NEM), which enhances PS 
externalization on plasma membrane, as well as necrostatin-1, a necroptosis inhibitor 
rescued the infected neutrophils from KPn mediated inhibition of efferocytic clearance. To 
our knowledge, this is the first report of inhibition of efferocytosis by KPn by PS 
redistribution and necroptosis, which likely promotes neutrophilia and persistent 
neutrophilic inflammation in this infection.        
 
 
 
Keywords: Efferocytosis; Klebsiella pneumonia; neutrophil turnover; phosphatidylserine; 
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Introduction 
Sepsis is one of the oldest and most elusive syndromes and despite extensive efforts to 
better understand and treat sepsis, it is still a major challenge in medicine (279). With no 
effective therapies there are over 750,000 cases of sepsis each year in the United States 
alone, which accounts for 10% of all ICU patients, leading to a mortality rate between 20-
50% depending on certain risk factors (2). Pneumonia is the most frequent cause of sepsis 
(223-225). In particular Klebsiella pneumoniae (KPn), an opportunistic pathogen, accounts 
for 5-20% of all Gram-negative sepsis cases (223, 225). A notable emergence of antibiotic 
resistant strains of KPn in clinical settings has caused concerns over an already dwindling 
armamentarium of antibiotics. In this scenario, elucidation of protective host immune 
responses and pathogen-mediated manipulation thereof will likely provide novel 
therapeutic targets.  
 
Neutrophils are the first cell types to infiltrate the site of infection and contribute to initial 
protective response. Indeed, in murine models of KPn infection, neutrophil-mediated 
responses are shown to be essential for initial control of the infection (248, 249). However, 
persistent accumulation of neutrophils and their over activation later causes neutrophil-
dependent inflammatory diseases in the lungs, including bacterial pneumonia and sepsis 
(114, 280). A profound neutrophilia and the role of released alarmins in perpetuation of 
inflammation in septic bacterial infections has been shown by us recently (65, 66, 89, 90, 
236). In Klebsiella infection, neutrophils have been reported to constitute a reservoir for 
this pathogen and aide in systemic dissemination of this infection (281). This underscores 
the importance of neutrophil turnover and resolution of neutrophil associated responses in 
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KPn pneumonia and sepsis. In this regard, clearance of neutrophils by phagocytic cells, 
mainly macrophages, occurs via efferocytosis which is a highly regulated receptor-
dependent process (282, 283). Recognition of surface exposed “eat-me” signal 
phosphatidylserine (PS), which replaces the native “don’t eat me” signals on apoptotic 
cells, by macrophage cell surface receptors initiates engulfment and engulfment-associated 
downstream signaling events that induce a pro-resolving macrophage phenotype (284-
286). Concomitantly, efferocytosis has been documented to play a vital role in controlling 
inflammation, by preventing the release of pro-inflammatory mediators from dead cells as 
well as by clearing pathogens not destroyed through phagocytosis (114, 157). While there 
is considerable research done on the efferocytosis pathways and its effect on disease 
development, studies on pathogen subversion of this important protective host response 
and the underlying mechanisms are extremely limited. Whether KPn can directly 
manipulate efferocytosis to promote disease is completely unknown.  
 
In this study we determined if KPn infection of neutrophils modulates their clearance via 
efferocytosis by macrophages. Our results presented in this manuscript show that KPn 
inhibits efferocytic clearance of neutrophils by causing a live infection- and time-
dependent decrease in the surface exposure of “eat-me” signal PS on the infected 
neutrophils as well as by driving the cell death away from immunologically silent apoptosis 
to a more inflammatory necroptosis pathway. Concomitantly, restoration of PS on KPn 
infected neutrophils as well as inhibition of necroptosis rescued the efferocytic uptake of 
these cells. Our studies present evidence for novel virulence mechanisms of KPn causing 
neutrophil turnover deficit which likely contributes to the genesis of KPn dissemination 
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and neutrophilic inflammation. PS and necroptosis targeted therapies may be useful to treat 
KPn infections in the face of constant emergence of antibiotic resistant strains of this 
bacterium.  
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Materials and Methods 
Bacterial strains and Mice 
The KPn (ATCC strain 43816) were grown to log phase in LB medium at 37oC. For 
isolation of cells and in-vivo experiments 6-8 weeks old wild-type C57BL/6 bred in the 
animal facility of the University of North Dakota were used. The animals were handled 
according to the institutional and federal guidelines.  
Flow cytometry analysis of “Eat-me and “Don’t eat me” signals 
Peritoneal neutrophils isolated from mice 12-16 hrs after intraperitoneal injection with 
sterile 4% thioglycollate (BD Biosciences, San Jose, CA) as described by us previously 
(65, 236). Purity was ensured by quantitating Ly6G+CD11b+ cells by flow cytometry (85-
90 % neutrophils).  Isolated neutrophils were left uninfected or infected with 10 MOI of 
KPn. Cells were stained with PerCP-Cy5.5 labelled anti-CD31 (Biolegend, San Diego, 
CA) or FITC abelled anti-CD47 (Biolegend, San Diego, CA) antibodies to detect “Don’t 
eat-me” signals by flow cytometry as described by us (65, 236). A FITC Annexin V 
Apoptosis Detection Kit (BD Biosciences, San Jose, CA) was used according to 
manufacturer’s instructions followed by flow cytometry analysis at indicated times to 
enumerate percentage of PI- Annexin V+ cells with surface exposed “Eat-me” signal PS 
using BD LSR II flow cytometer (Becton Dickinson, San Jose, CA). FlowJo (Tree Star) 
software was used to analyze the data.    
In-vivo Efferocytosis 
Peritoneal neutrophils were infected with KPn (MOI 10) for 2 hours before killing of 
extracellular, non-internalized bacteria with antibiotics, then labelled with 
Carboxyfluorescein succinimidyl ester (CFSE; Cell Trace™ CFSE Cell Proliferation Kit 
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from Invitrogen) per manufacturer’s instructions. CFSE-labelled infected or uninfected 
neutrophils were suspended in complete RPMI and 35uL/3.5x106 cells were administered 
intranasally into mice anaesthetized using a mixture of 30mg/ml ketamine and 4 mg/ml 
xylazine in PBS. Lungs were lavaged as described by us (65, 236) 2 hrs after the instillation 
and alveolar macrophages analyzed by flow cytometry using PE-Cy7 conjugated anti-
F4/80 and APC conjugated anti-Ly6G antibodies (BioLegend, San Diego, CA).  
Efferocytic uptake by macrophages was quantitated by flow cytometry to enumerate Ly6G- 
F4/80+ CFSE+ cells. Efferocytic index was calculated as the percent difference between 
uninfected and KPn infected neutrophils. All other statistical analyses were performed 
using the Student t test (SIGMA PLOT 8.0, Systat Software, San Jose, CA). 
In-vitro Efferocytosis 
Peritoneal neutrophils and macrophages were isolated 12-16hr and 5 days respectively after 
intraperitoneal injection of sterile 4% thioglycollate. Macrophages were seeded on 6 well 
plates at a density of 0.5x106 cell/ml for 1-2 hr before adding CFSE-labelled uninfected or 
KPn infected neutrophils (prepared as described above) at a ratio of 5:1. After 2 hrs cells 
were thoroughly washed, scraped and stained with PE-Cy7 conjugated anti-F4/80 and APC 
conjugated anti-Ly6G antibodies for flow cytometry. For some experiments, uninfected 
and infected neutrophils were treated with 5 mM of N-ethylmaleimide (NEM) or 
neutralizing antibodies against CD31 and CD47 (BioLegend, San Diego, CA), or with 
necroptosis inhibitors necrostatin-1 (100 µM) or GSK’872 (3 µM) (Millipore Sigma, St. 
Louis, MO) before incubating with macrophages. Efferocytic index was calculated as 
described above. 
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Western blot Analysis 
For detection of necroptosis markers, peritoneal neutrophils uninfected or infected with 10 
MOI KPn for 3 hours were lysed with RIPA buffer and probed with anti-mouse Caspase 
8, RIPK1 antibodies (Cell Signaling Technology, Danvers, MA) and pRIP3 S232 & T231, 
pMLKL S345 antibodies (Abcam, Cambridge, MA) by immunoblot analysis. 
Glyceraldehyde 3-phosphate dehydrogenase (GAPDH) was used as loading control. 
Peritoneal neutrophils treated with 1 μM Smac mimetic AT‐406 and 20 μM Q‐VD for 30 
min prior to stimulating with 100 ng/mL mouse TNF‐α were used as positive control for 
necroptosis induction (287). 
 
Statistical analyses  
Statistical analyses were performed using the Student t test (SIGMA PLOT 8.0, Systat 
Software, San Jose, CA). A   p value of ≤ 0.05 was considered statistically significant. 
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Results 
KPn infection inhibits efferocytosis of neutrophils  
In order to determine the effect of KPn infection on efferocytosis of neutrophils, we 
compared the uptake of CFSE labelled uninfected or KPn infected neutrophils by 
macrophages using flow cytometry. As shown in Figure 23A, after 3 hrs of incubation with 
CFSE labelled neutrophils, 32.7% ± 5.4% macrophages stained positive for uptake of 
uninfected neutrophils. On the other hand, only 13.9% ± 1.6% macrophages had 
efferocytosed KPn infected neutrophils which was significantly lower than their uninfected 
counterparts. This indicated that infection of neutrophils with KPn caused a significant 
reduction in their efferocytic uptake by macrophages. Importantly, this infection-induced 
inhibition was largely dependent on live bacteria and/or active bacterial replication because 
heat-killed KPn were significantly less potent in inhibiting efferocytosis of neutrophils 
causing a reduction only by 29.1% ± 2.3% of the uninfected neutrophils, compared to live 
bacteria which inhibited the efferocytosis by 57.2% ± 1.4% (Figure 23B). 
 
We next investigated if KPn infection can inhibit efferocytic clearance of neutrophils in-
vivo in lungs by alveolar macrophages.  For this, CFSE labelled uninfected or KPn infected 
neutrophils were inoculated intranasally into anesthetized mice followed by isolation and 
flow cytometry analysis of alveolar macrophages as described in methods. Consistent with 
our in-vitro results, KPn infection of neutrophils reduced their efferocytic uptake by 45.1% 
± 1.6% compared to the uninfected cells (Figure 23C).  Together, these data strongly 
suggested that KPn infection inhibits the efferocytic clearance of neutrophils by 
macrophages in-vitro and in-vivo. 
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Figure 23. Live KPn infection inhibits efferocytosis of neutrophils  
Neutrophils left uninfected or infected with live (A) or heat-killed (B) KPn at MOI 10 for 
2 hours were labelled with CFSE and incubated with macrophages at 5:1 ratio for 2 hours. 
The cells were washed thoroughly and the macrophages were processed for flow-cytometry 
by staining with anti-F4/80 and anti- Ly6G antibodies. The percent of Ly6G-F4/80+CFSE+ 
cells indicating macrophages that have internalized CFSE labelled neutrophils calculated 
from 5 independent experiments is shown in the representative density plots. The 
efferocytic index was calculated as the percent difference between uninfected and KPn 
infected neutrophils, (**, p<0.005; ***, p<0.001).  
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Figure 23 cont. Live KPn infection inhibits efferocytosis of neutrophils  
(C). CFSE labelled uninfected or KPn infected neutrophils were instilled intranasally in 
anaesthetized mice (3.5 million cells in 35 µl PBS). Two hours later lungs were lavaged as 
described in methods and cells were stained with PE-Cy7 conjugated anti-F4/80 and APC 
conjugated anti-Ly6G antibodies for flow cytometry.  Efferocytic uptake by macrophages 
was quantitated by enumeration of Ly6G- F4/80+ CFSE+ cells. Efferocytosis of uninfected 
neutrophils was taken as 100% and efferocytic index was calculated as the percent 
difference between uninfected and KPn infected neutrophils. Data are from 3 mice per 
group in 3 independent experiments (**, p<0.005). 
 
Effect of KPn infection on “don’t eat me” signals expressed by neutrophils 
Expression of specific cell surface molecules called the “don’t eat me” signals on healthy 
cells prevents their efferocytosis by phagocytes (288). We determined if impaired 
efferocytosis of KPn infected neutrophils could be attributed to these negative regulatory 
signals. Flow cytometry analysis showed that KPn infected neutrophils exhibited 
significantly increased surface expression of CD47 and CD31, two well-defined “don’t eat 
me” signals, as compared to the uninfected neutrophils (Figure 24A). However, 
upregulation of these signals on KPn infected neutrophils did not appear to contribute to 
the inhibition of their efferocytic uptake since the inhibitory effect of KPn infection 
remained intact even after blocking neutralization of CD47 and CD31 individually or in 
combination (Figure 24B). This indicated to us that “don’t eat me” signals do not play any 
significant role in KPn mediated inhibition of neutrophil efferocytosis.  
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Figure 24. “Don’t eat me” signals do not play any role in efferocytic inhibition of KPn 
infected neutrophils 
(A). Neutrophils were left uninfected or infected with KPn (MOI 10) for 3 hrs. Cells were 
then co-stained with antibodies against neutrophil marker Ly6G and the “don’t eat me” 
signals CD31 and anti-CD47. Each bar represents percent of Ly6G positive neutrophils 
expressing CD31 or CD47.  Data are mean ± SEM from 4 independent experiments (*, 
p<0.05).  (B). CFSE labelled neutrophils uninfected or infected with KPn were incubated 
with 5µg/mL anti-CD47 or anti-CD31 blocking antibodies individually or in combination 
30 min. prior to incubating with macrophages for 2 hrs.  Efferocytic uptake by 
macrophages was quantitated by flow cytometry using neutrophil specific anti-Ly6G and 
macrophage specific anti-F4/80 antibodies to enumerate percent of efferocytic cells. 
Numbers on the representative density plots show percent of Ly6G- F4-80+ CFSE+ cells 
from 3 independent experiments.  
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KPn infection of neutrophils causes reduced exposure of “eat me” signal 
phosphatidylserine 
We next examined if modulation of “eat-me” signal on neutrophils played any role in KPn 
mediated inhibition of efferocytosis. Phosphatidylserine (PS) is externalized to the plasma 
membrane of apoptotic cells, and has been classically characterized as an “eat me” signal 
essential for the recognition and efferocytosis by phagocytes (288). We thus compared the 
kinetics of PS externalization in uninfected and KPn infected neutrophils by flow 
cytometry using Annexin V which binds to PS. Propidium iodide was used to exclude 
necrotic cells from analysis. As shown in Figure 25A, uninfected neutrophils exhibited 
surface exposure of PS after 30 min. of culture, which gradually increased over a period of 
5 hrs.  The KPn infected neutrophils, on the other hand, showed similar levels of PS 
exposure as their uninfected counterparts for the initial two hours (19.7% ± 3.3% in KPn 
infected and 19.3% ± 4.6% in uninfected neutrophils). By 3 hrs post-infection, however, a 
drastic reduction in PS exposure was observed in KPn infected neutrophils (9.7% ± 1.9% 
in KPn infected compared to 21.8% ± 6.5% in uninfected neutrophils) which remained 
significantly lower than that in the uninfected cells up to 5 hrs (2.5% ± 0.3% in KPn 
infected compared to 33% ± 7.1% in uninfected neutrophils), the time at which the 
experiment was terminated. Importantly, this sharp decrease in the PS exposure in KPn 
infected neutrophils at 3 hrs coincided with the time by which these neutrophils were 
incubated with macrophages for efferocytic uptake, indicating that this phenomenon is 
likely responsible for the reduced uptake of KPn infected neutrophils by macrophages. This 
reduced PS exposure was not due to necrosis as the number of PI positive cells did not 
increase over time (data not shown).  
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KPn infection activates necroptosis in neutrophils 
As PS exposure is regarded a measure of apoptotic cell death, given the reduced PS 
exposure we examined if KPn infection modulates the cell death mechanism of neutrophils. 
In this regard, Caspase 8 is centrally positioned to control the extrinsic pathway of 
apoptosis as well as necroptosis by activating caspase 3 and 7 and by degradation of RIPK1, 
which is required for recruitment of RIPK3, eventuating in phosphorylated mixed lineage 
kinase domain-like protein (MLKL)-dependent necroptosis. Western blot analysis of 
Caspase 8 and RIPK1 in uninfected and KPn infected neutrophils showed reduced 
processing of procaspase 8 into active Caspase 8 (Figure 25B). This coincided with the 
reduced degradation of RIPK1 in these cells, indicating inhibition of apoptosis and 
activation of necroptosis. Indeed, phosphorylation of RIPK3 and MLKL was increased in 
KPn infected neutrophils confirming the activation of necroptosis in these cells upon 
infection (Figure 25B). As a positive control neutrophils treated with TNF-alpha in 
combination with caspase inhibitor Q-VAD were analyzed for necroptosis activation in the 
absence of caspase-8 activity, which showed a similar inhibition of caspase 8 processing 
and RIPK1 cleavage and increased phosphorylation of RIPK3 and MLKL (Figure 25B first 
lane). Taken together these data strongly suggested that KPn infection inhibits apoptosis, 
a cell death favorable for efferocytic clearance and instead activates pro-inflammatory 
necroptosis of neutrophils.    
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Figure 25 KPn infection decreases the level of surface exposed “eat me” signal 
phosphatidylserine (PS) on infected neutrophils and induces necroptosis 
(A). Neutrophils were left uninfected or were infected with KPn (MOI 10). The level of 
“eat me” signal PS was monitored by over time by Annexin V staining using a Annexin V 
Apoptosis Detection followed by flow cytometry analysis. Propidium iodide (PI) was used 
to exclude necrotic cells. Percent of Annexin V+ PI- cells at indicated times is shown (mean 
± SEM from 5 independent experiments; *, p<0.05; p**<0.005). 
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Figure 25 cont. KPn infection decreases the level of surface exposed “eat me” signal 
phosphatidylserine (PS) on infected neutrophils and induces necroptosis 
(B). Immunoblots for caspase-8, RIPK1, pRIPK3 and pMLKL in whole cell lysates from 
uninfected and KPn infected neutrophils are shown. Lysate from primary neutrophils 
treated with TNF-α with pan-caspase inhibitor Q‐VD and Smac mimetic was used as 
positive control for necroptosis activation. GAPDH was used as loading control.   
 
Restoration of PS exposure and inhibition of necroptosis rescues the efferocytic uptake of 
KPn infected neutrophils 
Given our data showing KPn-infection induced necroptosis and reduced externalization of 
PS, we determined if restoration of PS and necroptosis inhibition will rescue the efferocytic 
uptake of KPn infected neutrophils. In this regard, treatment with a sulphydryl modifying 
agent N-ethylmaleimide (NEM) triggers flipping of PS to outer plasma membrane of cells 
(289-291). As shown in Figure 26A, NEM treatment of KPn infected neutrophils reversed 
the PS exposure on their surface as 52.1% ± 7.7% cells stained positive for Annexin V 
staining by flow cytometry at 3 hrs as compared to the untreated KPn infected neutrophils 
on which the PS exposure remained low (9.9% ± 2.1%). Having established that NEM 
treatment could reverse KPn infection-induced reduction of PS surface exposure, we next 
tested if efferocytic uptake of KPn infected neutrophils was improved following NEM 
treatment. Indeed, reversal of PS externalization upon NEM treatment restored the 
efferocytic uptake of KPn infected neutrophils to the levels of uninfected neutrophils which 
was significantly higher than the untreated KPn infected cells (26.5% ± 1.7% NEM treated 
KPn infected Vs 10.1% ± 1.8% of untreated KPn infected) (Figure 26B).  
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To establish the role of KPn induced necroptosis in efferocytosis inhibition, we similarly 
treated KPn infected neutrophils with necrostatin-1, a RIPK1 inhibitor which suppresses 
necroptosis (292). As shown in Figures 26 C and D, treatment with necrostatin-1 reversed 
the inhibitory effect of KPn infection on efferocytic uptake of neutrophils by restoring it to 
the levels similar to uninfected cells. Necrostatin-1 treatment itself did not affect the 
efferocytosis of uninfected cells. Because necroptosis-independent functions of RIPK1 
have been reported (293), we also tested the effect of RIPK3 inhibitor GSK’872 to further 
confirm the role of necroptosis in inhibition of efferocytosis of KPn infected neutrophils. 
Indeed, GSK’872 treatment of KPn infected neutrophils increased their efferocytic uptake 
by macrophages to 80% (Figure 26 E and F).  This strongly implicated the activation of 
necroptosis as an important mechanism underlying impaired effrocytosis of KPn infected 
neutrophils.  Interestingly, RIPK1 or RIPK3 inhibition did not affect the level of 
externalized PS in the infected neutrophils (data not shown), indicating that necroptosis 
induction and PS exposure are, likely two independent mechanisms which KPn employs 
to inhibit the efferocytosis of neutrophils. Taken together, these data showed that KPn 
infection inhibits the efferocytic clearance of neutrophils by reducing the surface exposure 
of PS, a classical “eat-me” signal as well as by driving the cells to necroptosis. 
Consequently, restoration of exofacial PS as well as suppression of necroptosis pathway 
reverses this inhibitory effect of KPn infection. 
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Figure 26. Restoration of PS exposure and inhibition of necroptosis rescues the 
efferocytic uptake of KPn infected neutrophils 
(A). Treatment with N-ethylmaleimide (NEM) rescues surface exposed “eat me” signal PS 
in KPn infected cells and restores efferocytosis. The level of surface exposed PS in 
uninfected or KPn infected neutrophils with or without NEM treatment (5mM for 30 min) 
was measured by Annexin V staining followed by flow cytometry. Percent of Annexin V+ 
PI- cells at 3hrs post-infection is shown (mean ± SEM from 3 independent experiments, 
**p<0.005; ***, p<0.001).  (B) Uninfected and KPn infected neutrophils were treated or 
left untreated with NEM. The efferocytosis of these cells by macrophages was performed 
followed by flow cytometry as described above. Numbers on the representative density 
plots show percent of Ly6G- F4/80+ CFSE+ efferocytic cells (mean ± SEM) from 3 
independent experiments. (C&E) Efferocytic index and (D&F) percent of Ly6G- F4/80+ 
CFSE+ cells efferocytosing uninfected and KPn infected neutrophils with and without 
treatment with RIPK-1 inhibitor Necrostatin-1 (C&D) or RIPK3 inhibitor GSK’872 
(E&F). Data is presented as (mean ± SEM) from 3 independent experiments. 
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Discussion 
During an acute injury neutrophils are promptly recruited to the site which, upon the 
resolution of insult, are cleared by efferocytosis to maintain homeostasis (114). Given its 
host protective consequences, subversion of efferocytosis may be advantageous for 
pathogens to establish infection. Here we report that Klebsiella pneumoniae, an 
opportunistic pathogen causing pneumonic sepsis characterized by neutrophilia and 
hyperinflammation, prevents efferocytic clearance of neutrophils. We show that a down 
modulation of cell surface exposure of PS, an “eat-me” signal recognized by the 
phagocytes for efferocytic internalization of neutrophils, and modulation of cell death 
mode toward necroptosis are the underlying mechanisms by which KPn subverts 
efferocytosis. Our study provides important insights into pathogenic mechanisms that can 
be targeted for future antimicrobial therapies for this infection. 
 
KPn has recently gained attention as a “successful” pathogen owing to an emergence of 
hypervirulent strains as well as antibiotic resistance (294).  The wide range of infections 
caused by this pathogen in immunocompromised and immune-competent individuals have 
become increasingly difficult to treat owing partly to the arsenal of virulence factors 
exhibited by this pathogen that it utilizes to protect itself from host immune response (295). 
Based on these virulence factors KPn has been categorized as an “evader” rather than an 
“offender” pathogen. For example, a polysaccharide capsule, lipopolysaccharide, Type 1 
and 3 fimbrae and outer membrane proteins have been identified and characterized as 
factors required for survival and growth of the pathogen within the host (176). Our results 
presented in this manuscript, show for the first time, strategies employed by this pathogen 
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to actively suppress an important host defense i.e. efferocytic clearance of neutrophils by 
modulation of cell death pathway and PS externalization. Our data showing 
downregulation of PS exposure, reduced activation of apoptosis executioner Caspase 8 and 
activation of necroptosis in neutrophils infected with KPn highlight strategies employed 
by this pathogen to impair efferocytic clearance of these cells by macrophages. In this 
regard it is important to note that a recent report showed neutrophils as vehicles for KPn 
for its dissemination to establish liver abscess, a severe clinical complication of KPn 
infection (281). Efferocytic clearance of KPn-infected neutrophils thus may aid in 
circumventing these distant metastatic complications, as has been shown in case of 
mycobacterial infection (157).  These findings open new avenues to treat and prevent the 
systemic spread of this infection.   
 
Efferocytic clearance of apoptotic cells is a highly orchestrated event involving specific 
receptors on phagocytic cells that discriminate live cells from dead/dying cells by 
recognizing “don’t eat-me” and “eat me” signals respectively (288).  Phosphatidyleserine 
(PS) is considered the most well-characterized “eat-me” signal recognized by the 
phagocytes via receptors such as Bai1 and Tim4 for removal of apoptotic cells (296). 
Owing to an efficient and immunologically silent nature of this event, many viruses and 
parasites have been reported to use PS mimicry by concentrating PS on their surface and 
hijack efferocytic machinery of host cells to promote their internalization and cell-to-cell 
spread (159, 297, 298). In contrast to this, pathogen -mediated skewing of efferocytic 
clearance of immune cells via PS recognition is much less studied. Staphylococcus aureus 
is shown to inhibit efferocytic clearance of neutrophils via upregulation of CD47, a “don’t 
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eat me” signal and necroptosis (160). In our study “don’t eat me” signals, although 
upregulated on neutrophils upon infection, did not appear to play any significant role in 
inhibition of efferocytosis. Instead, KPn infected neutrophils showed a drastic down 
modulation in the externalization of “eat-me” signal PS.  PS distribution on the lipid bilayer 
in biological membranes is controlled by the activity of ATP-dependent flippases and 
scramblases (299). Flippases contribute to PS maintenance in the inner leaflet via ATP 
dependent transport of phospholipid from the outer to inner membrane. Scramblases on the 
other hand, transport PS to the outer leaflet. Whether the decreased PS exposure on the 
outer membrane of KPn infected neutrophils is due to KPn mediated modulation of 
flippases and scramblases, is an exciting area of mechanistic research which we are 
currently pursuing. Notwithstanding the molecular mechanism, the relevance of this event 
was confirmed by reversal of PS exposure on KPn infected neutrophils by NEM treatment 
which rescued their efferocytic clearance.  To the best of our knowledge, this is the first 
report of pathogen mediated inhibition of PS exposure on neutrophils to avoid their 
efferocytic clearance. PS-dependent clearance of immune cells results in the release of anti-
inflammatory and pro-resolving factors which downregulate the inflammation (300). In 
addition, recent studies have shown that efferocytic uptake of apoptotic neutrophils 
regulates granulopoiesis and peripheral neutrophilia via an IL-23/IL-17/G-CSF axis (262). 
KPn mediated inhibition of neutrophil clearance may result in the loss of this negative 
regulatory axis thus promoting the neutrophilia and inflammation characteristic of this 
infection. In addition, maintenance of neutrophilic niche may help disseminate the 
infection to systemic sites.  
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Necroptosis is defined as a caspase-independent non-apoptotic form of regulated cell death 
which requires RIPK1 and RIPK3-mediated activation of pseudokinase, mixed lineage 
kinase-like protein (MLKL)  (301). Extrinsic pathway of apoptosis activated by death 
ligands such as FasL or TLR ligands promotes processing of caspase-8 which degrades 
RIPK1 and drives apoptotic cell death (302). Conversely, inhibition of caspase 8 spares 
RIPK1 to promote RIPK3 autophosphorylation and recruitment of MLKL to form a 
necroptosome complex (303). Phosphorylation of the C-terminal pseudokinase domain of 
MLKL by RIPK3 promotes MLKL translocation to plasma membrane which then disrupts 
the membrane integrity (304). Our results showed reduced processing of caspase 8 in KPn 
infected neutrophils indicating the inhibition of apoptosis in these cells. This coincided 
with increased RIPK1 levels, RIPK3 phosphorylation and MLKL phosphorylation strongly 
suggesting the activation of necroptosis pathway in KPN infected neutrophils. This 
supports the notion that KPn drives the cell death away from immunologically silent 
apoptosis which favors efferocytosis, toward necroptosis which lacks “eat-me” signals and 
promotes inflammation (305). While inhibition of apoptosis by KPn has recently been 
reported (306), our studies present physiological consequence of this phenomenon 
eventuating in reduced PS externalization and modulation of cell death pathway relevant 
to KPn infection induced inhibition of efferocytosis. This is supported by increased 
efferocytic uptake of infected neutrophils upon treatment with NEM to increase PS 
exposure as well as with necrostatin-1 and GSK’872, which are inhibitors of necroptosis. 
It is noteworthy here that necroptotic fibroblasts and monocytic cell lines were recently 
reported to expose PS on their surface in pMLKL-dependent fashion (307, 308). While 
these findings indicate a novel function of necroptosis pathway in PS exposure in these 
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cells, the inhibition of PS exposure and induction of necroptosis in KPn infected primary 
neutrophils in our studies appears to be via two independent pathways since inhibition of 
necroptosis did not affect the levels of PS on KPn infected neutrophils (data not shown). 
In light of our results showing the rescue of efferocytosis upon increased PS exposure by 
NEM treatment as well as upon inhibition of necroptosis it is highly likely that KPn utilizes 
two independent strategies to inhibit the clearance of neutrophils and to drive the 
neutrophilia and inflammation characteristic of pneumonic infection. As the antibiotic 
resistance is a serious problem associated with Klebsiella infections, elucidation of 
mechanism by which this pathogen manipulates efferocytosis, as reported here, might 
provide novel therapeutic targets.    
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CHAPTER 5 
DISCUSSION 
General Discussion 
As described in the Introduction section, sepsis continues to be a major healthcare burden. 
Despite decades of dedicated research efforts, occurrence of sepsis and septic shock is 
rising and the mortality rate has not changed over the past three decades (309, 310). A 
likely reason as to why it has been so difficult to find effective treatment for sepsis is that 
immune regulatory processes that respond to sepsis are not completely understood (273, 
311). An overwhelming inflammatory response, termed “cytokine storm” or 
hypercytokinemia resulting from stimulation with pathogen-derived (PAMPs) or host-
derived factors (alarmins) is thought to be responsible for shock, multiple-organ failure and 
eventual death in septic patients (23). However, anti-inflammatory interventions have not 
been a successful treatment option for sepsis. This highlights the need to take into account, 
not only the initiation of inflammation, but also the resolution thereof, which favors tissue 
repair. In this regard, neutrophil mediated responses are essential for combating pneumonic 
bacterial infection and their protective role in sepsis has been described (248, 249). 
However, persistent accumulation of neutrophils can lead to bystander tissue destruction, 
owing to their tissue destructive cargo. Neutrophil turnover and resolution of neutrophil 
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associated responses is thus, an integral part of a resolving inflammatory response to an 
infectious insult such as pneumonic infection. My dissertation revolves around the 
hypothesis that a failure of this process likely contributes to the acceleration of 
inflammation resulting in the development of sepsis. This is a highly understudied area of 
research. The studies described here provide an understanding of the host factors regulating 
neutrophil mediated responses and their perturbations by pathogen in a setting of 
pneumonic sepsis, which will likely provide new targets for therapeutic intervention of this 
deadly immune disorder.  
In chapter 1 I presented an overview of the disease burden, inflammatory immune 
responses, clearance of dead cells via efferocytosis, mechanisms by which bacteria subvert 
host immune response to establish infection, and animal models used to study sepsis. 
Chapters 2 and 3 elucidated the protective roles of the CLRs, MGL1 and Mincle, in 
pneumonic sepsis. In chapter 4, a novel mechanism by which the pathogen KPn, modulates 
the host response in order to prevent its clearance via efferocytosis was presented. The 
remainder of chapter 5 will summarize and discuss the new findings from this work. 
 
Protective role of CLRs during inflammation and sepsis 
C-type lectin receptors (CLRs) are considered pattern recognition receptors (PRRs) and 
have been shown to play a role in numerous inflammatory and homeostatic host functions 
(82). Surprisingly, little is known about the role of CLRs in the development of pneumonic 
sepsis.  We set out to characterize the function of CLRs in pneumonic sepsis using our KPn 
infection model. Initial transcript level screening of more than 60 CLRs showed several 
CLRs upregulated at in the lungs of these pneumonic septic mice. I focused on two of those 
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CLRs namely Macrophage Galactose Type Lectin 1 (MGL1) and Mincle (Clec4e). We 
found that in the absence of either of these CLRs, mice were highly susceptible to KPn 
infection compared to WT mice and most mice succumbed to infection by 5 days post 
infection. This data suggested that both MGL1 and Mincle play a protective role in 
pneumonic sepsis. In both MGL1-/- and Mincle-/- mice infected with KPn we observed 
severe lung pathology along with a hyperinflammatory response with massive increases in 
pro- and anti-inflammatory cytokines when compared to infected WT mice 3 days post 
infection. There was also a massive accumulation of neutrophils in the lungs of both 
infected CLR knockout mice compared to infected WT mice. However, a kinetic analysis 
of bacterial burden in these knockout mice showed disparate phenotypes. Whereas MGL1-
/- mice showed no difference in bacterial burden when compared to WT mice, Mincle-/- 
mice displayed increased systemic and local bacterial burden compared to WT mice. This 
indicated distinct roles of these two CLRs in KPn infection induced pneumonic sepsis. 
Considering a massive neutrophil influx in the absence of both MGL1 and Mincle, and the 
fact that both CLRs are expressed mainly by myeloid cells, we further analyzed the 
function of neutrophils in MGL1-/- and Mincle-/- mice. We found that while MGL1-/- 
neutrophils were fully competent in bacterial clearance mechanism (bacterial uptake by 
phagocytosis as well as NET formation), Mincle-/- neutrophils were defective in these 
functions. No functional defect seen in MGL1-/- neutrophils, but a massive influx of 
neutrophils into the lungs of infected MGL1-/- mice, indicated to us two possible scenarios. 
One possibility is that MGL1 plays a role in neutrophil influx and in the absence of MGL1 
the neutrophils infiltrate the lungs in increased numbers. The other possibility is a defect 
in the ability of MGL1-/- mice to clear apoptotic cells via efferocytosis thus causing their 
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increased accumulation in their lungs. To this end, we began by looking at the role of 
MGL1 in neutrophil influx by adoptive transfer experiments of WT and MGL1-/- 
neutrophils. Those experiments showed that the absence of MGL1 on neutrophils and not 
endothelial cells, led to the increased neutrophil influx as seen in MGL1-/- mice. Additional 
experiments looking into neutrophil mobilization markers, showed that by 3 days post 
infection MGL1-/- had significantly higher levels of GCP-2 and G-CSF, when compared to 
WT mice. The massive increase of G-CSF in the lungs of KPn infected MGL1-/- mice, 
suggested that emergency granulopoiesis could be occurring (252-261). We therefore 
examined the process of granulopoiesis in WT and MGL1-/- mice over a 3-day time course. 
The results of the experiments showed that by 3 days post infection, MGL1-/- mice exhibit 
an increase in mature neutrophil mobilization from the bone marrow to the blood when 
compared with WT mice. This could possibly be due to the increased levels of G-CSF 
observed in the lungs of KPn infected MGL1-/- mice. It has been shown that defects in 
efficient clearance of apoptotic neutrophils via efferocytosis leads to an increase in G-CSF 
production (262). It is possible then that a defect in MGL1-/- mice ability to clear apoptotic 
neutrophils drives the increased levels of G-CSF in MGL1-/- mice. In-vivo efferocytosis 
experiments to determine if MGL1-/- neutrophils are cleared as efficiently as WT 
neutrophils showed that indeed in the absence of MGL1, neutrophils were cleared less 
efficiently than the WT neutrophils. This result indicated to us that a defect in the clearance 
of apoptotic neutrophils in MGL1-/- mice during KPn infection, lead to increased 
production of G-CSF, and ultimately increased neutrophil influx into the lungs. Combined 
with the results of the adoptive transfer experiment it is possible that MGL1 negatively 
regulates neutrophil influx as well as aids in efficient clearance of apoptotic neutrophils via 
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efferocytosis. Future studies in the lab will determine the mechanisms by which MGL1 
plays a role in these processes. This study identified a novel role of MGL1 in pneumonic 
sepsis by regulating neutrophil influx through either the negative regulation of neutrophil 
influx, clearance of apoptotic neutrophils, or a combination of both.  
 
Our findings show that both MGL1 and Mincle play a protective role during KPn induced 
pneumonic sepsis and inflammation. MGL1 by regulating neutrophil influx into the lungs 
and Mincle by regulating bacterial clearance mechanisms through neutrophil phagocytosis 
and NET formation. These discoveries help identify novel mechanisms to be used in the 
development of treatments and therapies for sepsis. 
 
KPn’s modulatory effect on neutrophils and impact on efferocytosis 
Klebsiella pneumoniae (KPn) is an opportunistic pathogen known for causing hospital 
acquired pneumonic sepsis. It has become a pathogen of interest recently due to the 
emergence of multidrug resistant strains, which are even resistance to colistin, an antibiotic 
considered a last line of defense (177, 183, 184). Given that, it is critical that we understand 
the virulence factors, which aid in the ability of this pathogen to infect and survive in the 
host tissue. KPn has four well characterized virulence factors; capsule, lipopolysaccharide 
(LPS), fimbriae, and siderophores. KPn utilizes these virulence factors to evade rather than 
subvert an early host immune response. With our studies described in Chapter 4, we have 
identified a novel virulence mechanism by which KPN subverts a protective host response 
i.e. efferocytosis of neutrophils thereby maintaining a replicative niche (281). Our results 
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showed that KPn infected neutrophils were cleared less efficiently via efferocytosis than 
uninfected neutrophils. The mechanism underlying this inhibition appears to be different 
from what has been reported in case of Staphylococcus aureus where the pathogen inhibits 
the efferocytic uptake of infected cells by upregulating the surface expression of the “don’t 
eat me” signal CD47, while also inducing necroptosis (160).  Our results instead showed 
that while KPn does increase the expression of two “don’t eat me” signals in CD31 and 
CD47, neutralization of these signals has no effect on KPn induced inhibition of 
efferocytosis of infected neutrophils. Instead, KPn infection drastically reduced the surface 
exposure of the most well characterized “eat me” signal, phosphatidyleserine (PS). This 
decrease in cell surface PS exposure in KPn infected neutrophils coincided with the timing 
of our efferocytosis assay and suggested to us that KPn modulation of cell surface PS 
exposure was leads to the KPn mediated inhibition of efferocytosis of infected neutrophils. 
Indeed, reversal of PS exposure by treatment with NEM rescued the efferocytic uptake of 
infected cells. In this regard a  recent report showed that KPn infection delays apoptosis in 
human neutrophils (306). AS PS exposure is a characteristic measure of apoptotic cell 
death, our studies present the first evidence of physiological relevance of this phenomenon 
in KPn infection.  
We next determined if KPn could induce alternative routes of cell death Western blot 
analysis of caspase 8 and RIP1 via Western blot analysis in uninfected and KPn infected 
neutrophils showed that KPn infection inhibited caspase 8 activation, which in turn 
prevented RIP1 inactivation through cleavage. That indicated an activation of necroptosis 
in KPn infected neutrophils. An increased phosphorylation of downstream kinases RIPK3 
and MLKL confirmed this notion. Concomitantly, inhibition of necroptosis with 
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necrostatin-1 (RIPK1 inhibitor) as well as GSK’872 (RIPK3 inhibitor), rescued the defect 
in the efferocytosis of KPn infected neutrophils. The results of this study indicate that KPn 
infection inhibits apoptosis resulting in reduced PS exposure, while inducing an alternative 
cell death by necroptosis in neutrophils in order to inhibit their efferocytic clearance. The 
inhibition of efferocytosis through these mechanisms likely contributes to the development 
of a pro-inflammatory environment, which allows the pathogen to establish an infection, 
thus driving the development of sepsis. To our knowledge this is the first instance of a 
pathogen modulating PS exposure mechanisms in conjunction with induction of 
necroptosis to avoid efferocytic clearance. Understanding the mechanisms behind KPn 
modulation of PS exposure and induction of necroptosis could lead to novel therapeutic 
targets against KPn, which given the rise of antibiotic resistant strains is essential. Work is 
underway in the lab to determine the mechanisms leading to the molecular pathway 
underlying these aspects of KPn mediated inhibition of efferocytosis. 
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